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ABSTRACT
This thesis examines the effects of nerve growth factor (NGF) and
lithium on the regulation of neurotensin/neuromedin (NT/N) gene
expression in PC12 pheochromocytoma cells. In PC12 cells, the expression of
the rat NT/N gene is strictly dcpcndcnt on simultaneous exposure to
combinations of NGF, glucocorticoids, activators of adenylate cyclase, and
lithium. Transient transfection experiments indicatcd that a consensus AP-
site located within the NT/N promotcr is the principal target of NGF and
lithium action. NGF rapidly, but transicntly, induces the expression of several
AP-l genes in PC12 cells, suggesting that the effect of NGF on NT/N gene
expression results from increased AP- activity. These results led to the
prediction that the induction of NT/N gene exprcssion should be rapid,
transient and dependent on de novo protein synthesis. These experiments also
suggested that the NT/N gene is principally regulated through the initiation of
transcription. However, post-transcriptional mechanisms may also be
involved. Experiments in this thesis were designed to examine the regulatory
mechanisms responsible for increased NT production in PC12 cells when
treated with different inducer combinations and whether AP- factors could
act as mediators in responses to NGF and lilhium.
Results described in this thcsis indicate that the principal mechanism
by which NGF and lithium rcgulate NT biosynthesis is by activating NT/N gene
transcription. Comparison of NT/N mRNA, pro NT/N synthetic rates, proNT/N
proteins and malure NT levels in induced PC12 cells, demonstrated that NGF and
lithium had no effect on the translation of NT/N mRNA and had only a modest
Vlll
effect on post- translational proccssing. Nuclcar run-on assays showed that
NT/N transcription is transiently activated in maximally induced cells. A rapid
RNase protection assay was developed to examine both the kinetics of NT/N
gene activation and whether activation rcquires newly synthesized proteins.
Quantitation of nuclear 
NT/N precursor RNA, using a probe spanning the
junction between exon one and intron onc. provides a sensitive measure of
NT/N gene activity and by several criteria provides an accurate measure of
NT/N transcription. When eithcr NGF or lithium was combined with
dexamethasone and forskolin, nuclear NT/N precursor RNA transiently
accumulated, although each induccr displayed different kinetics, rapid and
delayed, respectively. De novo protein synthesis was not required for
activating NT/N transcription whcn NGF was used as the permissive agent,
although newly synthesized proteins sccm to be needed for subsequent down-
regulation. The response to lithium displayed a marked requirement for new
protein synthesis, consistcnt with the involvement of newly synthesized AP-
factors. RNA blot analysis showed that lithium either alone or in combination
with dexamethasone and forskolin induced c-jun and fra- gene expression
with delayed kinetics, consistent with c-Jun/Fra- l complexes mediating the
effects of lithium on NT/N gene transcription. The pathway identified by
lithium does not activate or rcquirc protein kinase C. This pathway is also
active in neuronally-differentiated PC12 cells suggesting that it could be
involved in the regulation of NT/N gene exprcssion in the intact nervous
system. These results and order of addition experiments demonstrate that NGF
and lithium activate distinct pathways required for NT/N gene induction.
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CHAPTER I
INTRODUcrION
Qve The neuropeptide, neurotensin (NT), has been implicated in diverse
functions in the CNS, including control of the estrous cycle and modulation of
dopaminergic pathways (Ervin and Nemeroff 1988). t;T and a related
neuropeptide, neuromedin N, are encoded by a common gene (NT/N gene)
(Dobner et al. 1987; Kislauskis et al. 1988) which is expressed throughout the
limbic regions of the rat central nervous system (CNS) in a complex pattern
(Alexander et al. 1989b). Several lines of evidence indicate that endocrine
hormones and. neurotransmitters play key region-specific roles in the
generation of this pattern. For example, estrogen and the antipsychotic drug,
haloperidol, have striking regulatory effects on NT/N gene expression in the
medial preoptic area (Alexander et a!. 1989b; Alexander et al. 1991) and the
striatum (Merchant et al. 1992; Merchant et al. 1991), respectively, suggesting
that diverse environmental stimuli are required to establish the complex
pattern of NT/N gene expression observed in the adult rat CNS.
PC12 cells, which differentiate neuronally in response to nerve growth
factor (NGF) (Greene and Tischler 1976), have provided insights into the
pathways through which neurotrophic factors and neurotransmitters control
gene expression. Among the earliest transcriptional responses to NGF in PC12
cells. is the rapid induction of the fos and c-jun proto-oncogenes (Sheng and
Greenberg 1990). These genes encode components of the AP- I family of.
transcription factors that recognize a common cis-regulatory sequence within
the promoters of many genes, including NT/N (Kislauskis and Dobner 1990;
Morgan and Curran 1991; Sheng and Greenberg 1990). A variety of
physiological and pharmacological stimuli induce AP- l gene and protein
expression in the central nervous . system, indicating that AP- I complexes may
play an important role in controlling neuronal gene expression (Morgan and
Curran 1991). The identification of functional AP- l-related sequences required
for the expression of genes encoding neurotransmitter biosynthetic enzymes
(Gizang-Ginsberg and Ziff 1990) and ncuropeptides (Kislauskis and Dobner
1990; Kobierski et ai. 1991; Sonnenberg et ai. 1989c) suggest that these genes
comprise an important class of neuronal AP- target genes. PC12 cells provide
a valuable model system for understanding how AP- regulates the expression
of this class of target genes.
The AP- site is closely related to the cyclic AMP response element or
.. 
CRE (Montminy et al. 1986). Thc transcriptional activation function of the
major CRE-binding protein in PC12 cells, CREB, is regulated in response to
cAMP through phosphorylation by protein kinase A (Gonzalez and Montminy
1989). However, similar to the AP- site, the CRE is recognized by a family of
. DNA binding proteins that are structurally related to the AP- family (Habener
Specific AP- l family protcins can also form heterodimers with CREB
proteins that bind thc CRE with high affinity (Benbrook and Jones
1990; Hai and Curran 1991; Ivashkiv et al. 1990). Since diverse stimuli induce
a wide variety of cells and the cAMP pathway is present in most
question concerning the regulation of target genes by
is how specificity is generated. The analysis of the
Kobierski et ai. 1991) and NT/N (Kislauskis
and Dobner 1990; Kislauskis and Dobner 1992) genes has provided evidence
that functional interdependence between AP- l-related, CRE-related, and other
cis-regulatory sequences may play an important role in determining which
target genes are activated through the AP- l and cAMP pathways.
NT/N gene expression in PCl2 cells is subject to synergistic regulation
by combinations of NGF, glucocorticoids, and adenylate cyclase activators
(Dobner et al. 1988). NGF is required for responses to glucocorticoids and
forskolin suggesting that it acts to permit NT/N gene expression. Lithium
which perturbs phosphatidylinositol signal transduction pathways (Berridge
et at. 1989) and blocks at least some NGF effects in PC12 cells (Burstein et al.
1985), is able to substitute for NGF in this permissive role (Dobner et al. 1988).
Increases in NT/N mRNA were not always paralleled by increases in
intracellular NT peptide, suggesting that post-transcriptional mechanisms
may also be regulated by NGF and lithium (Dobner et at. 1988). A rat NT/N gene
promoter fragment confers the regulatory properties exhibited by the
endogenous gene to reporter gcnes and contains a consensus AP- site, two
CRE-related sequences, and a glucocorticoid response element (GRE) which are
required for appropriate regulation (Kislauskis and Dobner 1990). Alterations
in the CRE and GRE motifs selectively affect responses to inducer combinations
that include forskolin or dexamethasone, respectively, whereas the AP- site is
likely to mediate the permissive effects of NGF and lithium (Kislauskis and
Dobner 1990). These results indicate that the consensus AP- site plays a
piVotal role in the transcriptional regulation of the NT/N gene and leads to the
prediction that NT/N gene activation in PC12 cells wil be both transient and
synthesis, since NGF and other stimuli transiently
in these cells (Sheng and Greenberg 1990).
Experiments described in this thesis were designed to test whether the
and lithium on NT/N gene transcription is
mediated by the induction of AP- factors.
ote Neurotensin, a thirteen amino aeid peptide, was originally
isolated from extracts of bovine hypothalamus based on its potent hypotensive
effects (Carraway and Leeman 1973: Leeman and Carraway 1982). NT is a
member of a family of related peptides, all having similar biological effects,
that possess as the major determinant of biological activity common carboxy-
terminal sequences (Carraway and Reinecke 1984). NT/N mRNA and NT-like
immunoreactivity are expressed most abundantly in the adult rat in the
gastrointestinal (GI) tract and are widely distributed in the CNS, most
significantly in the forcbrain and limbic system (Carraway and Leeman 1976).
In mammals, NT immunoreactive cells are scattered in the epithelium of the
jejunum- ileum where NT seems to play role in the regulation of fat
metabolism (Ferris et al. 1985). In the rat CNS, NT has been implicated in
regulating distinct systems. For instance, within the anterior medial preoptic
nucleus, NT/N mRNA levels are induced in response to estrogen treatment in
ovariectomized rats suggesting that NT neurons mediate stimulatory effects of
ovarian steriods on GnRH sccretion thus modulating the prc-ovulatory surge
. (Alexander et al. 1989a). NT also co-localizes to dopamine containing neurons
within rodent brains (Nemeroff et al. 1983) and exerts behavioral propenies
that resemble those of neuroleptics, antipsychotic drugs whose actions
correlate with dopamine 02 receptor antagonism (Merchant et al. 1991;
. . NeDleroff and Cain 1985). Trcatmcnt with the dopamine antagonist,
haloperidol , results in the rapid transient induction of both nuclear NT/N
precursor RNA and NT/N mRNA within the rat striatum (Merchant et al. 1992).
These results suggest that NT/N gene expression is specifically localized within
the rat CNS and that distinct environmental inputs are responsible for the
establishment of the complex pattern of expression.
Characterization of the NT/N gene and cloned cDNAs has provided clues
on how diverse environmental inputs regulate the specific pattern of
expression in the adult rat. Rat NT is synthcsized from a precursor peptide
(preproNT/N), of 169 amino acids, that also codes for a related peptide,
neuromedin N (Dobner et al. 1987). Sequences are highly conserved between
canine, bovine, human and rat prcproNT/N, which all exhibit a similar
prohormone structure (Kislauskis et al. 1988, and unpublished results). The
identification of sequences that are similar to neuromedin (NN) and that are
N-terminally flanked by dibasic amino acids suggests that an unidentified
peptide may be synthesized along with NT and NN. Typical of other secretory
et al. 1983), the NT/N precursor protein contains a consensus
at the amino-terminus. The preprohormone structure of NT/N
that intracellular NT content may be regulated at different levels,
initiation of transcription, mRNA splicing, and peptide processing.
The distribution of NT/N mRNA to regions of the CNS that also express
NT-like immunoreactivity suggest that the induction of transcription may 
the major mechanism for establishing tissue-specific localization. However, in
the rat' hippocampus and subiculum the detection of abundant NT/N mRNA
where NT-like immunoreactivity was not observed indicated that translational
posHranslational mechanisms may also regulate NT/N biosynthesis within
the CNS (Alexander et al. 1989b). Several other studies have also shown that
there is a difference in the regional distribution of intracellular NT, NN, and
extended forms of NT and NN in the mouse (Shaw et al. 1990b), dog (Carraway
and Mitra 1990; Carraway ct al. 1991), and rat (Carraway et al. 1991: Sato et al.
1990), indicating that alterations in post- translational processing contribute to
the tissue specific distribution of NT and the related peptides. Several examples
of differentially processed neuropeptides that are located within different
regions of the CNS have been documented, including preprotachykinin,
preproopiomelanocorticotropin, and proenkelphalin (Douglass et al. 1984).
Therefore, the regulation of NT/N gene transcription and peptide processing
may be responsible for the tissue specific localization of NT/N mRNA and NT
peptides within the CNS. Distinct environmental inputs which regulate
transcription, peptide processing, or other NT biosynthetic pathways are
likely to be necessary for the establishment of the this complex pattern of
distribution.
PC12 ce An excellent model for studying environmentally induced changes
in neuron-specific gene expression is the PC12 cell line. Isolated from a rat
pheochromocytoma, PC12 cells are thought to be representative of progenitor
the sympathoadrenal lineage (Greene and Tischler 1976; Greene and
1982). Sympathoadrcnal precursor cells arc derived from the neural
transient structure originating on the apical surface of the neural
tube. During embryogenesis, these cells migrate to form the peripheral
nervous system along with several non-neuronal cell types, including adrenal
(LeDouarin 1982). Scveral studies have shown that
differentiation of the sympathoadrcnal progenitors is dictated by the
environment to which they migratc (Anderson 1989; LeDouarin 1980). Two
such environmental determinants play both permissive and instructive roles
these phenotypic decisions: glucocorticoids, secreted from the adrenal
cortex, promote the differentiation of adrenal ehromaffn cells; whereas NGF,
secreted from target tissues, causes neuronal differentiation (Anderson and
Axel 1986). Like sympathoadrcnal precursor cells, unstimulated PC12 cells
resemble adrenal chromaffn cells. Furthermore, when exposed to NGF, they
cease to divide, and differentiate into cells that have all the characteristics of
sympathetic neurons (Grecne and Tischler 1976; Grcene and Tischler 1982).
Both NGF and glucocorticoids can alter the expression of many neuron-
specific genes in PC12 cells, including the tyrosine hydroxylase (Gizang-
Ginsberg and Ziff 1990) and NT/N genes (Dobner et al. 1988). Thus, PC12 cells
have become important in understanding the mechanisms by which
environmental factors, such as NGF, hormones, and neurotransmitters,
interact to induce gene expression.
tion facto In PC12 cells, NGF induces a class of "cellular
immedi ate early genes (lEGs) whose protein products are important
mediating the response extracellular stimuli changes gene expression.
Many these genes, which include the fosljun family proto-oncogenes,
code for transcription factors that preferentially bind heterodimers AP-
cis-regulatoFY sequences (5' TGA G/C TCA- ) on specific target genes 
(Herschman 1991). This family includes c-fos, at least three fos-related genes
(los B, fra- , fra- 2), c-jun, and at least two jun-related genes (jun-B, jun- D).
AP- factors are phosphoproteins comprised of at least two functional domains:
transactivation domain and a bZIP domain (Curran and Franza 1988; Curran
et al. 1987). The bZIP domain is comprised of a region of basic amino acids
along with a leucine zipper. An extensive number of studies have concluded
the following about the bZrp domain: 1) DNA recognition specificity resides in
the basic region: 2) the leucine zipper is responsible for dimerization which is
required for binding the DNA element: heterod imerizati on different
AP- factors allows for variability activation potenti al there
dimerization code which assures that only certain combinations leucine
zipper containing proteins can form stable dimers (Abate et al. 1991; Abate et
al. 1990; Kouzarides and Zi ff 1988: Ransone et aI. 1989: Sassone-Corsi et al.
1988b). Phosphorylation of AP- proteins within the transactivation and bZIP
domains can affect both DNA binding and transcriptional activation (Binetruy
et al. 1991; Boyle et aI. 1991). The presence of these domains in AP- l factors
thus allows for two different modes of regulation. phosphorylation and
dimerization.
Cellular lEGs are rapidly and transiently transcribed in PC12 cells in
response to extracellular stimuli in a protein synthesis independent manner
(Greenberg et al. 1986; Morgan and Curran 1989). For example, transcriptional
activation of c-fos occurs within 5 minutes of NGF treatment in PC12 cells, and
continues for 15-20 minutes (Grccnberg et aI. 1985). c-fos mRNA accumulates
and reaches peak values at 30 -45 minutes post-stimulation; thereafter it
declines with a relatively short half-life of approximately 12 minutes (Morgan
and Curran 1991). Synthesis of c- fos protein follows mRNA expression and it 
turned over with a half- life of about 2 hours (Morgan and Curran 1991). A
model of how environmental stimuli can regulate gene transcription, by
inducing Ap. factors, is depicted in Figurc 1- 1. Ligands binding to cognate
receptors act through signal transduction pathways to induce AP- l gene
Figure 1- Model for the regulation of target gene expression by the
induction tof AP- factors. Ligands (L) binding to receptors (R) activate signal
transduction pathways (step 1) that induce AP- l gene tr-anscription (step 2).
AP-l mRNAs are processed and transported into the cytoplasm (step 3) where
they are translated (step 4). Ncwly translated AP- proteins are modified and
translocated . into the nucleus (step 5). These factors bind to the AP- site
within the promoter of a target gcnc as dimers (step 6) and activate
lranscription (step 7). Each gene is depicted with a regulatory region (dark
shaded boxes) and a transcribed region (open boxes). mRNAs are shown as
by poly A tracts. The AP- l protein domains are
N-terminal region (light shaded boxes), DNA binding (horizontal
and leucine zipper region (diagonal stripes). Solid thin line
represents the cellular membrane while the double thin line represents the
nuclear membrane.

transcription. AP- I mRNAs are processed and transportcd to the cytoplasm
where they are translated. Newly translated proteins are modified,
translocated into the nucleus and bind to AP- sites either as homo- or
of target genes. Extracellularheterodimers thereby activating transcription
stimuli could regulate the synthesis or activity of AP- proteins at any one of
these steps, although induction of AP- I gene transcription or the post-
translational modification of AP- proteins are the most likely mechanisms.
Subsequent attenuation of target gene transcription is normally achieved
through autorepression of AP- l genes coupled with the unstable nature of
both AP- mRNA and proteins (Sassone-Corsi et al. 1988c). However,
inactivation can also be achicved by inducing AP- factors that negatively
regulate transcription (Chiu et al. 1989). Following stimulation, specific AP-
genes are expressed with varying kinetics (Bartel et al. 1989; Sonnenberg et al.
1989a), suggesting that there is a tcmporal alteration in the composition of the
AP- l complex. The relative levels of active or inactive AP- factors, at any
given time after stimulation , could mediate the response to neuropeptide gene
transcription.
Induction of AP- l genes during stimulation of the intact nervous system
thcse genes are important regulators of neuronal gene
rapid and transient induction of c-fos, fra- and c-jun
rodent brain in response to various stimuli,
drug- induced seizures (Morgan et al. 1987), electrical stimulation
(Sagar et al. 1988) and pcripheral sensory stimulation (Naranjo et al. 1991).
Several neuropeptide genes, including the proenkephalin (Sonnenberg et al.
1989a) and prodynorphin genes (Naranjo et al. 1991), are rapidly and
transiently expressed in parallel with AP- I genes following stimulation,
although with slightly delayed kinetics. Even though this is only correlative
evidence, these experiments strongly suggest that the induction of AP-
complexes are involvcd the control of ncuropeptide genc expression.
Therefore, cellular lEGs, especially AP- l binding factors, may function as
third messenger mediators of long- term responses to environmental faetors
within the nervous system.
eurote in r in P 12 ell The localization of NT to cells of the cat
adrenal gland (Terenghi ct al. 1983) suggested that NT might also be expressed
in PC12 cells and could be used as a model system to study how environmental
factors regulate neurotensin genc expression (Tischler et al. 1982). NT- like
immunoreactivity was detected in PC12 cells, but only after induction with
combinations of NGF, forskolin, and the synthetic glucocorticoid,
dexamethasone (Tischler et al. 1986). Naive cells were devoid of NT, as were
cells treated with individual inducers. Dexamethasone and forskolin only
affected NT levels when used in combination with NGF, indicating that NGF acts
permissively to facilitate the actions of both dexamethasone and forskolin.
Surprisingly, lithium chloride could substitute for NGF in its permissive role
(Dobner et al. 1988), evcn though it has been shown to antagonize the effects
of NGF on neurite outgrowth in PCl2 cells (Burstein ct al. 1985). Lithium alone
had no effect on NT expression in PC12 cells, whereas it acted synergistically
with NGF, dexamethasone and forskolin to increase NT content (Dobner et ai.
1988). Therefore, NT cxprcssion in PC12 cells is strictly dependent on combined
treatment with multiple inducers.
- - -..- - -- - -
In most cases, increases in the levels of NT/N mRNA in response to
combinations of NGF, lithium, dexamethasone, and forskolin paralleled
increases in intracellular NT content indicating that the major mechanism for
regulating NT Icvcls in PCl2 cells is lhrough the activation of NT/N gene
transcription (Dobner et al. 1988). A promoter fragment encompassing
sequences between -216 and +56 con fers the regulatory properties exhibited
by the endogenous gene to rcporter genes, indicating that NT/N gene
expression is regulated principally at the transcriptional level (Kislauskis and
Dobner 1990). Detailed mutational analysis of this region has provided
evidence that a consensus AP- site, two CRE-related sequences, and a
glucocorticoid response elemcnl (GRE) are required for appropriate
regulation. Alterations in the CRE and GRE motifs selectively affected
responses to inducer combinations that include forskolin and dexamethasone,
respectively (Kislauskis and Dobner 1990). Dcletion or mutation of the AP-
element reduced responses to all inducer combinations by about an order of
magnitude, suggesting that the AP- site mediates the permissive effects of
NGF and lithium (Kislauskis and Dobner 1990). The selective activation of CAT
fusion genes driven by multimerized consensus AP- sites in response to
either NGF or lithium in PC12 cells also supports this view (Dobner et al. 1992).
These results indicate that AP- faetors mediate the permissive actions of NGF
and lithium.
model for the transcriptional regulation of the NT/N gene is shown in
2. NGF or lithium, acting through signal transduction pathways,
the binding of Fos!Jun complexes to the AP- site. CREB-like proteins
. constitutively bound to the distal CRE are activated by forskolin, presumably
1 5
Figure 1- Model for the cooperative induction of the NT/N gene. NGF, lithium,
dexamethasone, and forskolin, acting via signal transduction pathways
(arrows), induce NT/N gene expression through the interaction of DNA
binding proteins with the NT/N promoter. NGF and lithium act through
Fos!Jun dimers (stripled/open circles) that bind to the distal AP- site.
Forskolin activates the cAMP signalling pathway to induce the
phosphorylation of CREB (open boxes) bound to the distal CRE. Dexamethasone
stimulates translocation of GC receptors to the nucleus (shaded boxes) which
then bind to the GRE. It is unclear whether Fos!Jun complexes or CREB interact
with the proximal CRE/AP- site. The multi factor complex cooperatively
interacts with basal transcription factors (BTFs, shaded circle) bound at the
TATA box and enhanccs the initiation of RNA polymerase (RNA pol, shaded
circle), thus activating transcription of the NT/N gene.
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through phosphorylation by protein kinase A (PKA). Activated glucocorticoid
receptors bind to the GRE. This multifactor complex then interacts with the
basal transcription machinery resulting in an increase in NT/N transcription.
It is unclear which signalling pathway interacts with the proximal CRE/AP-
site. since it is composed of sequences that resemble both an AP- l site and CRE
(Kislauskis and Dobner 1990). Interestingly, the CRE differs from the AP- site
by the insertion of a single base-pair (Montminy et al. 1986). Recent gel shift
and DNase footprinting cxperiments demonstrated that both CREB and various
AP-l complexes interact! with this dual element, in vitro (G. McNeil and P.
Dobner, unpublished results). The interaction of proteins bound to these
mutually dependent regulatory elements allow for . the synergistic activation
of NT/N transcription. NT/N gene expression in PC12 cells appears to be an
excellent experimcntal model to study how the coordination of multiple
environmental stimuli ncuropeptide biosynthesis, especially changesregulate
in gene transcription.
Even though increases in NT/N mRNA levels seem to be the major
response to these inducers, post-transcriptional mechanisms may also control
intracellular NT content (Dobner et al. 1988). In cells treated with lithium,
dexamethasone,and forskolin, the level of NT/N mRNA increases 348-fold while
intracellular NT increases just 4-fold as compared with cells exposed to only
the latter two inducers (Dobner et al. 1988). In contrast, treatment of PC12 cells
with NGF, dexamethasone, forskolin, and lithium results in only a 2. fold
increase in NT/N mRNA whereas a 24- fold increase in intracellular NT was
observed when compared to with cells treated with only the latter three
inducers (Dobner et al. 1988). These results indicate that NGF and lithium can
1 8
influence eithcr the processmg evcnts requircd for the generation of the
mature NT peptide or steps involved in the intracellular compartmentalization
of NT.
rans
Nerve gro h factor - NGF is the prototype of a family of "neurotrophic
factors , that are necessary for the function and survival of both peripheral
and central neurons (Barde 1989; Thoenen and Edgar 1985; Walicke 1989). NGF
is secreted by target tissucs, where it is taken up by nerve terminals and
retrogradely transported to the neuronal soma to regulate cellular processes
(Levi-Montalcini 1987). The rcceptors for NGF have not been fully defined,
although two forms, low and high affinity, have been identified (Vale and
Shooter 1985). Charactcrization of the proto-oncogene trk suggests that it may
be the homolog of the NGF receptor. Trk protein binds NGF with high affinity
and both trk mRNA and protein are expressed mainly within the peripheral
nervous system (Martin-Zanca et al. 1989). A homologous receptor TrkB, which
preferentially binds two other neurotrophic factors, BDNF and neurotrophin-
3, is strongly expressed in the ccrebral cortex and hippocampus, but barely
detectable in the peripheral nervous system (Soppet et al. 1991; Squinto et al.
1991). These observations indicate that various neurotrophic factors act in a
manner within the nervous system. Trk, which like the isolated
high affnity NGF receptor from PC12 cells, has tyrosine kinase activity,
suggesting that NGF may act through a second messenger pathway involving
multiple phosphorylation steps. As of yet, the actual substrates of the Trk
tyrosine kinase have not becn idcnti fied, allhough two likely candidates are
phospholipase C-O and MAP kinases (Boulton et al. 1991; Chan et al. 1989). NGF
stimulates phosphorylation of phospholipase C-5 on serine and tyrosine
residues (Kim et al. 1991), potentially activating the phosphatidylinositol
signal transduction pathway (Chan et al. 1989). NGF has also been shown to
activate MAP2 kinases, othcrwise known as extracellular signal-regulated
kinases (ERKs), by phosphorylation on both tyrosine and serine/threonine
residues (Boulton et al. 1991). Since Trk tyrosine kinase appears to trigger not
one but multiple signal transduction pathways, NGF signals may diverge into
several independent pathways (Ross 1991). NGF binds to cognate receptors,
thereby initiating second messenger pathways leading to the phosphorylation
of substrates important for both short and long-term changes in neuronal
plasticity.
lin - The cAMP second messenger signal transduction cascade has
been well characterized (Suthcrland 1972). Ligands activate adenylate cyclase
through receptor-coupled G-proteins. Forskolin, a lipid soluble molecule
extracted from the perennial aromatic herb, Coleus forskohli, directly
activates the catalytic subunit of adenyl ate cyclase (Seamon and Daly 1981).
Adenylate cyclase converts ATP into cAMP which acts as an intracellular
ligand to liberate the regulatory subunit of protein kinase A (PKA). The
activated PKA subunit phosphorylates a wide range of substrates, including
proteins that influence the activation of gene transcription (Gizang-Ginsberg
and Ziff 1990; Kislauskis and Dobner 1990; Kobierski et al. 1991). cAMP's effect
on transcription is mediated by various members of a family of CREB-like DNA
binding proteins. These factors bind, either as monomers or dimers, to a
common consensus sequence (5' TGACGTCA- ) which acts like a classical
enhancer (Habener 1990). cAMP responsc elements (CRE) are highly
conserved among several cAMP- inducible promoters (Montminy et aI. 1990),
including the NT/N gene (Kislauskis and Dobner 1990), and have been shown
to be both necessary and sufficient for responsiveness to cAMP signalling
(Montminy et aI. 1990). CREB is a 43 kDa phosphoprotein , which similar to AP-
factors, is subdivided into two domains: a transactivation domain and a bZIP
domain. PKA phosphorylates CREE- within a phosphorylation rcgion (P-box) of
the amino- terminal transactivation domain which is necessary for activation
(Habener 1990; Lee et aI. 1990: Yamamoto et al. 1988). However,
phosphorylation by PKA was not sufficient to activate transcription (Merino
et al. 1989) thus additional phosphorylations by PKC or caseine kinase II may
be necessary for full activation (Lee ct al. 1990). Downstream of the
transactivation domain lies the bZIP domain, consisting of the basic amino acid
DNA binding domain and a carboxy-tcrminal leucine zipper (Habener 1990;
Montminy et aI. 1990). The identification of the leucine zipper suggests that
various members of the leucine zipper family, such as CREB, CRE-BPI, ATFs or
AP- factors, can heterodimcrizc (Benbrook and Jones 1990). Similar to the AP-
factors, CREB can bc rcgulated by two different modes, phosphorylation and
dimerization. CREB is the major CRE binding protein in PC12 cells (Montminy
and Bilezikjian 1987) and is likely to mediate the transcriptional effects of
forskolin on the NT/N gene. Recent in vitro DNA binding and footprint assays
have demonstrated that bacterially produced CREB binds in vitro to both the
proximal and distal CRE within the NT/N promotcr (G. McNeil and P. Dobner,
unpublished rcsults).
m - Lithium inOucnces components of two well characterized
transduction pathways, the coupling between receptors and G-proteins
2 1
and perturbations of the phosphatidylinositol (PI) signalling pathway.
Experiments which analyzed the cffects of lithium on the adrenergic and
cholinergic stimulation of GTP binding in rat cortex indicated that lithium
competes with magnessium ions. These ions are cssential for the binding 
GTP to G-proteins thus lithium can interfere with G-protein linked signal
transduction pathways, such as the cAMP signalling cascade (Avissar et al.
1988). Lithium also has a profound affect on the PI signalling pathway. Figure
diagrams the metabolic events that occur during signallng through this
pathway. Ligand stimulated receptors activate phospholipase which
hydrolyzes phosphatidylinositol (PIP2) into diacylglycerol (DAG) and inositol
triphosphate (IP3) (Berridge and Irvine 1984: Nishizuka 1984). DAG is a strong
activator of protein kinase C (Huang 1989; Nishizuka 1984). IP3, specifically
I(1,4,5)P3, mobilizes calcium from the endoplasmic reticulum (Berridge and
Irvine 1984), which greatly innuences cellular processes, such as activating
calcium/calmodulin kinases (Griffith and Schulman 1988). Protein kinase C
(PKC) and calcium/calmodulin kinase both potently alter gene expression
(Chiu et al. 1987; Sheng et al. 1991: Van Nguyen et al. 1990) and are thus
important mediators for translating extracellular stimuli into transcriptional
responses. Lithium acts as an uncompctitive inhibitor of mono- and
polyphosphatases, which are important for recycling inositol phosphate
metabolites back into free inositol. This recycling is thought to be necessary
for the regeneration of the signa II ing pathway (Berridge et al. 1989; Nahorski
et al. 1991), especially where dietary inositol is unavailable. The inhibition of
these phosphatases causes thc accumulation of mostly inactive metabolites,
although in GH3 cells there is an accumulation of DAG after treatment with
Figure 1- Lithium perturbs the phosphatidylinositol signal transduction
pathway. ligand (L) binding to its cognate receptor (R) activates
phospholipase C (PLC). This enzyme converts phosphatidylinositol diphosphate
(PIP2) into diacylglycerol (DAG) and inositol triphosphate (IP3). These
metabolites strongly activate signal transduction cascades (shown as broken
arrows), DAG through the activation of protein kinase C (PKC) or IP3 by the
mobilization of calcium (Ca ) and subsequent activation of
calcium/calmodulin kinases (CCK). Both these pathways can lead to alterations
in gene expression. The regeneration of the signalling system (thin arrows)
involves the synthesis of phosphatidylinositol (PI) from free inositol,
generated from dephosphorylation of the inositol phosphate metabolites (IP4,
IP3. IP2 and IPl), and phosphatidic acid (PA) derived from the metabolism of
DAG. Lithium inhibits monophosphatases (thick arrows) needed to regenerate
free inositol. In an environment where inositol uptake is limited, this could
lead to a depletion of PIP2 and an accumulation of the biologically active
metabolite, DAG.
In
os
ito
l
PI
P
C
C
K
 
-
-
-
.
-
-
-
 
PK
C
G
en
e 
ex
pr
es
sio
n
In
os
ito
l
(in
ac
tiv
e)
I
P
3 
--
--
--
-
(ac
tiv
e) 
,
t
 
Ql
lithium (Drummond and Raeburn 1984). These observations raised the
possibilty that lithium influences NT/N gene expression as a result of its
effect on the PI signal transduction pathway.
xam aso ne - Dexamethasone is a potent synthetic glucocorticoid
that mimics the action of cortisol and other corticosteroids (Norris 1980).
Glucocorticoids (GCs), like other steroid hormones, are derived from
cholesterol and released into the circulatory system by endocrine organs. The
lipid-soluble nature of GCs allow them to diffuse through target cell
membranes where they interact with intraccllular receptors. GC initiates the
release of the active receptor from a cytoplasmic complex , the GC receptor
associated with the 90 kd heat shock protcin (hsp90). The activated GC receptor
translocates across the nuclear membrane and binds as a dimer to cis-acting
elements on target genes to activate transcription. DNA sequences (GREs)
responsible for rcgulation by GC hormones are found in many genes (Evans
and Arriza 1989; Yamamoto 1985) and share elements of a IS-mer consensus
sequence (5' GGTACAnnnTGTTCT- ) (Beato 1989). Structural analysis has
demonstrated that the GC receptor is a member of a superfamily of related
receptors that share a common mode of action (Evans 1988) and are similarly
organized into different functional domains (Beato 1989). Invariant cysteine
residues that form zinc fingcrs arc found within the ccntral domain
(Freedman et al. 1988) and are responsiblc for the specific binding to the GRE
(Hollenberg 1987). Immediately adjacent to the zipper region is a short
sequence that is responsible for intranuclear localization (Picard and
Yamamoto 1987) and the interaction with hsp90 (PraLt et al. 1988). The
carboxy-terminal domain contains residues important for ligand binding,
along with those nccded for dimerization, which may be a prerequisite for
effcient trans-activation (Kumar and Chambon 1988). Scquenccs located
within amino-terminal (tau 1) and the carboxy-terminal ligand binding
regions (tau 2) and are both neccssary and sufficient for trans-activation
(Giguere et al. 1986). The tau sequences are rich in acidic residues (Hollenberg
and Evans 1988) and, thus may have ccrtain properties in common with acidic
yeast activator sequenccs (Sigler 1988). The amino-terminal domain, which
shows the greatest variability betwcen receptors, seems to play a modulatory
role in transactivation (Beato 1989). By functioning as ligand-dependent
transcription factors, GC receptors play a key role in hormone signal
transduction within the ncrvous systcm.
Tra ion ner Onc of the unique features of NT/N gene induction
in PC12 cells is the high dcgrce of syncrgy observed between different
environmental stimuli. NGF and lithium act cooperatively with forskolin and
dexamethasone to cnhance NT/N gene cxpression in PCl2 cells (Dobner, et at.
1988; Tischler et al. 1986). Promoter analysis has indicated that different cis-
regulatory elements mediatc responses to the permissive agents NGF and
lithium, activators of adcnylatc cyclase, and glucocorticoids, and that the
functional interdependence of thesc elements account for the synergistic
action of these inducers (Kislauskis and Dobner 1990; Kislauskis and Dobner
1992). Synergistic interaction between transcription factors bound to distinct
regulatory sites have been documented (Jantzen et al. 1987; Sabol and Higuchi
1990; Schule et al. 1988a: Schule ct al. 1988b). It is unclear how synergy is
generated between the regulatory elements within the NT/N promoter. One
possibility is that coopcralivity of binding bctwecn transcription factors can
occur, of which several examples have been described, such as the
glucocorticoid receptor synergizing with NFl, CPl and SPI transcription
factors (Schule et al. 1988a; Strahle et al. 1988). Interestingly, the degree of
synergism is inversely related to the strcngth of the GRE (Schule et al. 1988a).
This mechanism may be relevant to NT/N gene expression, since GRE and CRE
sequences, within the NT/N promoter, deviate from consensus and thus may be
weak binding sites. Another possibility is that the combined activation
potential of the transcriptional complex , bound to the promoter, is greater
than the sum of cach individual factor. Experiments with GAL4 derivatives
transfected into mammalian cells have suggested that this second possibilty is
likely to occur in eukaryotic cells (Carey et al. 1990). Cooperati vity between
different transcription factors, bound to adjaccnt AP- l, CRE and GRE sites in
the NT/N promoter, controlled by distinct signalling pathways, could account
for the highly syncrgistic induction of NT/N gene cxpression in PC12 cells.
Cooperativc interactions of multiplc signal transduction pathways could
occur through a single cis-regulatory elcment. This model may be particularly
important in the synergistic induction of the NT/N gene by NGF and lithium,
in combination with dexamethasone and forskolin. Transient transfection
assays have demonstrated that both NGF and lithium activate multimerized
concensus AP- sites linked to rcportcr genes (Dobner et al. 1992). Even
though these experimcnts showed that the effects of NGF and lithium were
additive, the observed synergy betwcen NGF and lithium on endogenous NT/N
gene expression in PC12 cells could occur through the distal AP- site, which
may act differently in the context of the NT/N promoter. As shown in figure 1-
NGF and lithium could interact at the distal AP- site utilizing either common
(A) or separate (B) signalling components. An example in support of the first
possibility is the activation of the human a-gonadotropin gene (hCG) by both
cAMP and phorbol estcrs (Hoerner et al. 1989). Both PKA and PKC are involved
in activating the hCG gene through an AP- site, known in this gene as a TPA-
response element (TRE). The function of either kinase alone results in a
moderate level of activity, whereas both of the stimulated kinases
synergistically activate transcription (Hoerner et aI. 1989). An example of the
second case is the induction of both Fos and Jun proteins by various stimuli.
Jun homodimers have minimal effects on AP- containing promoters whereas
the Fos!Jun heterodimcrs strongly activate gene transcription (Chiu et a1.
,,,
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1988: Sassone-Corsi ct aI. 1988b). Dctcrmining whether NGF and lithium
interact by similar or distinct signalling pathways to influence NT/N gene
transcription, is one of thc major questions addressed in this thesis.
:j:
The signalling pathways utilized by NGF and lithium could act
synergistically through thc induction of AP- factors. A likely mechanism by
which signalling pathways act on a single AP- site is through activation of
different leucine-zipper factors. Members of the Jun family can form
heterodimers with members of the Fos family. While these heterodimers are all
capable of binding to AP- l sitcs (Cohen et a1. 1989: Halazonetis et al. 1988;
Nakabeppu et al. 1988) some of them form either aCLive (Chiu et al. 1988;
Sassone-Corsi et al. 1988b) or inactive transcriptional complexes (Chiu et aI.
1989; Schuttc et al. 1989). The ability of AP- l and CRE-binding proteins to
heterodimerizc thus altcring both DNA binding and transactivation provides
another mechanism for syncrgistic interactions at this site. c-Jun has been
Figure 1- Models for thc synergistic intcraction of NGF and lithium at the
distal AP- site. A. Lithium (Li) and NGF could intcract through a common
signallng pathway to induce multiple AP- factors. These proteins would
heterodimerize and bind to the AP- site. B. Lithium and NGF could act via
separate signalling pathways to inducc different AP- factors which would
heterodimerize and bind to thc AP- 1 si tc.
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shown to heterodimerize with CRE-BPl and thc resulting complex has the
binding specificity of a CRE-binding protein (Hai and Curran 1991: Hurst et al.
1990; Ivashkiv et al. 1990). The formation of dimers from factors induced
by distinct signal transduction pathways expands the rcpertoire of sequence-
specific DNA binding complexes.
Post-translational modi fications of induced or pre-existing AP- factors
could also account for the synergistic action of NGF and lithium on the AP-
site. Since many AP- l and olher leucine zipper factors are highly
phosphorylated, this model likely (Angel and Karin 1991; Habener 1990).secms
good example of how multiple phosphorylations can synergistically activate
transcription factors is shown with the CRE-binding protein, CREB. Within the
transactivation domain thcre are conscnsus sequences for PKA, PKC, and
casein kinase II (Gonzalez ct al. 1989). Phosphorylation by PKA of CREB at
serine- l 191131 is required for transactivation, although it does not seem to be
sufficient, suggesting that other phosphorylations are required for activation
(Lee et al. 1990). This serine residue is also phosphorylated by calmodulin-
dependent kinases, indicating that distinct phosphorylation cascades can
influence the activity of CREB , at the same phosphorylation site (Sheng et al.
1991). Phosphorylation 0 f CREB by PK C is rcq ui red for efficient dimerization
(Yamamoto et al. 1988). Taken, together these results indicate that the
activation of CREB depends on multiple phosphorylations, that result from the
activation of distinct signalling pathways. In further support of this
conclusion , procnkephalin gene expressIOn is synergistically activated by
membrane depolarization and activation of adenylate cyclase by independent
pathways, which converge on a single CRE within the proenkephalin
3 1
promotcr (Van Nguyen eL al. 1990). Therefore, the post-translational
modification of transcription factors plays an integral role in developing
transcriptional synergy.
rim This thcsis focuses on the rolc that NGF and lithium
play in regulating NT/N gcne cxpression and the biosynthesis of the 
peptide in PC12 cells. Experimental evidence strongly supports the role of
these two permissive agcnts, in combination with dexamethasone and
forskolin, in activating NT/N transcription, however they may also be
involved in regulating translational or posL- translational events (Dobner et al.
1988; Kislauskis and Dobner 1990). Two questions were initially proposed: 1) do
combinations of thesc inducers influcncc the translation of NT/N mRNA or
processing of proNT/N protcin and 2) do thcy activate NT/N transcription.
Analysis of proNT/N protein synthcsis in metabolically- labeled PC12 cells,
utilzing antiserum raised against a fusion protein containing preproNT/N
sequences, showed that NGF and lithium do not influence the translation of
NT/N mRNA, whereas lithium modestly altcred the proteolytic processing of
proNT/N. Nuclear run-on transcription assays dcmonstrated that NT/N gene
transcription is transiently activated in maximally stimulated PC12 cells,
although at low levels. A RNase protection assay, used as an indirect assay for
transcription, showed a Lransient activation of nuclear precursor NT/N RNA
which closely paralleled the kinctics of activation of nuclear run-on
transcripts. Taken togethcr, thcse results confirm that NGF and lithium, in
combination with dexameLhasonc and forskolin, primarily act by inducing
NT/N genc transcription.
The kinetics of precursor NT/N RNA in maximaIly treated cells are
consistent with the induction of AP- factors mediating the response to NGF
and lithium. Previous experiments indicated that the AP- site, located within
the NT/N promoter, is necessary for thc rcsponse to both NGF and lithium
(Kislauskis and Dobner 1990). Since NGF and activity of other stimuli rapidly
induce AP- l gene and protein expression in PC12 cells, NT/N gene expression
should be dependent on de novo AP- protein synthesis. Pre-treating
maximally induced PC12 cells with protein synthesis inhibitors showed a
marked attenuation in NT/N gene expression consistent with the involvement
of transiently exprcssed AP- I complexes. Surprisingly, protein synthesis
inhibitors did not atlenuatc the response to NGF, dexamethasone and forskolin,
suggesting that post-translational modification of pre-existing AP- factors
may be mediating the response LO NGF. The requirement of de novo protein
synthesis on the induction of NT/N gcnc expression in PC12 cells treated with
lithium, dexamethasonc and forskolin suggesLed Lhat AP- factors could be
mediating the response to lithium. RNA blot analysis of PC12 ceIls induced by
lithium alone or in combination with dexamethasone and forskolin indicated
that c-Jun/Fra- l complexes may be mcdiating thc rcsponse to lithium.
When either NGF or liLhium is used as the permissive inducer, two
different kinetic profilcs were observed, rapid and delayed, respectively.
These results together with the observation that NGF and lithium each display
distinct requirements for ongoing protcin synthesis suggested that each is
acting through a distincL signalling pathway. Order of addition experiments
were done to confi rm th is concl usion. Long-tcrm di fferentiation studies
indicated that the pathways identified by NGF and lithium are available in
neurons. Finally, experiments wcre done to assess whethcr PKC activity is
necessary for the activation by lithium. Both in vitro PKC activity studies and
protein kinase C down-regulation experiments demonstratcd that PKC activity
did not mcdiate the rcsponse to lithium. Togcthcr these expcriments show that
NGF and lithium act through distinct signalling pathways which may be
available in neurons, although the response to both agents does not require
the activation of PKC. They also suggest that potentially novel modes of AP-
regulation underlie the synergistic activation of NT/N gene expression in PC12
cells.
CHAPTER II
TRANSCRIPTIONAL ACTIVATION OF THE
NEUROTENSIN/NEUROMEDIN N GENE IN PC12 CELLS
The expression of thc NT/N gene is synergistically induced in PC12 cells
by combinations of NGF, lithium , glucocorticoids, and activators of adenyl ate
cyclase (Dobncr et aI. 1988). Several lines of evidence have indicated that these
agents mainly act by increasing transcription of the NT/N gene (Dobner et al.
1992; Kislauskis and Dobner 1990). However, in some induction conditions,
particularly those that include NGF and lithium, the relative levels of NT
peptide did not always parallel that of NT/N mRNA , suggesting that
translational or post- translational mcchanisms may also by involved (Dobner
et al. 1988). The first set of cxpcrimcnts were dcsigned to examine whether
these inducers rcgulate the induction of NT in PC12 cells at the level of
transcription, translation of NT/N mRNA or the processing of proNT/N.
Previously describcd experiments indicated that an AP- cis-regulatory
element within the promoter of the NT/N gene mediates the response to NGF
and lithium, suggesting thc NT/N promotcr is a targct for AP- l complexes
(Dobner et aI. 1992: Kislauskis and Dobncr 1990). This leads to the prediction
that the response of NGF and lithium , in combination with dexamethasone and
forskolin, on NT/N transcription will be rapid and transient, consistent with
newly synthesized AP- factors mediating the effect. Detailed kinetic analysis
of nuclear NT/N precursor RNA, detected by RNase protection, was performed
to test this prcdiction. Rcsults presented in this chapter show that
combinations of thcsc inducers primarily regulate NT/N gene expression
through the activation of transcription, and that the gene is activated with
different kinetics whcn either NGF or lithium is used as the permissive
inducer.
Neurotensin Protci n B iosyn thesi sPrccursor
n of ntiserum the recursor protein To examine the
potential effects of NGF and lithium on translation or processing of the NT/N
precursor peptide (proNT/N) an immunoprecipitation assay was developed
using rabbit antiserum raised against a bacterially produced fusion protein
containing rat proNT/N scquenccs. Antibodies specifically generated against
the precursor protein were needcd, since anti-NT pcptide antibodies were
ineffective in detecting proNT/N (Robcrt Carraway, personal communication).
To generate antiserum spccific for the NT/N precursor peptide, rabbits were
immunized with a fusion protein TrpE- NT/N. Thc Pvu II - Bam HI fragment of
the rat NT/N cDNA clone (rbNT), containing nearly thc entire coding region
(lacking the first 7 amino acids) along with 200 nucleotides of 3' un translated
region, was subcIoned in- frame into the Sma 1 site of pATH 2 to produce pATH-
rbNT (figure 2- 1 A). pATH2 contains thc E. coli tryptophan promoter and
operator, from which hcterologous protcins linkcd to the trp LE 1413 protein
can be efficiently synthesized (Kleid et aI. 1981). The LE segment, containing
the trp leader (L) peptide along with a third of the trp E protein, is 190 amino
acids in length (approximately 39 kd). Fusion proteins derived from pATH2
constructs arc insoluble inside bacteria, thus protecting them from proteolytic
degradation. This also greatly aids in purification of the fusion protein
products, since thcy can be recovered in the ccllular debris of lysed E. coli.
After transformation of pA TH-rbNT into E. coli, induction by indoleacrylic acid
resulted in the production of large amounts (-lmg/IOO ml media) of TrpE-NT/N
with the cxpccted molecular weight of 56 kd
Figure 2- NT/N sequences and plasmid constructions used for producing
antibodies to the NT/N precursor protein. A. The rat cDNA (open boxes) was
ligated to either a fragmcnt of the bactcrial trpE gene (diagonal lines) in
pATH-rbNT, or to a fragment coding for the first seven residues of canine
NT/N (grey box) in pGEM-crhNT. Thick lines represent 3' untranslated region
and thin lines are 5' untranslated and vector sequences. The restriction sites
used for the ligations arc indicated. Transcription of pGEM-crhNT with T7 RNA
polymerase produces sense RNA used for in vitro translation of full length
NT/N precursor protein. B. A Coomassie stained SDS/polyacrylamide (10%) gel
that shows full length TrpE-rbNT (56 kd) induced in HB 101 bacterial cells.
Protein markers (M) are shown , with sizes denoted on the left in kilodaltons
(kd). Proteins cxtracted from cells left untrcated (-) or induccd with 50 Ilg/m I
of indoleacrylic acid (+) arc shown. The amount of TrpE-rbNT was quantitated
by comparison with BSA (68 kd) standards (20, 10, 4 Ilg respectively)
(figure 2- 1 B).
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The insoluble proteins wcre rcsolved by SDS-PAGE and the appropriate band
was excised. The gel slice was homogenized with Freund's adjuvant and
approximately 300 Ilg were injected subcutaneously into each of two New
Zealand whitc rabbits. This was followed by a boost of approximately 150 Ilg per
rabbit, two weeks later. Blood was collectcd, serum prcpared and analyzed in an
immunopreci pi tation assay.
Specific antibodies werc titered by an immunoprecipitation assay
utilizing in vitro translatcd protcins produced from synthetic NT/N RNA. To
obtain synthetic RNA coding for the full Icngth NT/N precursor peptide, the
Pvu 11- Eco RI fragment of rbNT was ligated to the Hind II - Pvu II fragment
of the canine NT/N cON A and subcloncd into the Hind III - Eco RI site of pGEM4
to produce pGEM-crhNT (figure 2-2A). This construction was necessary since
the rbNT cDNA clone did not contain an in- frame initiator methionine codon.
The hybrid protcin contains 162 amino acids of rat preproNT/N along with the
first 8 residues of canine preproNT/N. of which only 4 are unique to the dog.
Synthetic crhNT RNA , transcribcd with T7 RNA polymcrase, was translated in
rabbit reticulocyte Iysates, and 35 S- Iabclcd proteins were imm unoprecipitated
using formalin- fixed Staphylococcus aureus (Staph A) and specific antiserum.
Antiserum from Rb 3 was shown to have a good titer; 1 :400 dilution precipitates
nearly all the input protcin. This antiscrum was specific for NT/N since no
protein product was prccipitatcd from in vitro translations of testis RNA.
Antiserum Rb 3 was used to detcct precursor NT/N protein in metabolically
labeled cclls to cxamine the influcnce 0(' NGF and lithium on the translation of
NT/N mRNA and protcolytic processing of proNT/N.
Met olic labeling of NT recursor roteins in PC12 cells. To follow the
appearance of newly synthesized NT/N precursor protcins in induced PCl2
cells, proper pulse- Iabcling conditions wcre established. Continuous labeling
experiments using -5 X 106 PC12 celIs in 1 ml of labeling medium demonstrated
that between 25 and 30 pcrccnt of the total 3H- leucine (20 j.Ci) was linearly
incorporated into acid insolublc material within one hour. In some cases, both
3H-Ieucine (20 j.Ci) and 35 S-methionine (60 j.Ci) were used to enhance
detection of the NT precursor protein.
ProNT/N synthetic rates were determined by immunoprecipitation of 
vivo- labeled PC12 celI lysates with antiserum Rb 3. PC12 cclIs were treated with
NGF, lithium, dexamcthasone, and forskolin for 24 hours, to induce NT/N mRNA
to maximal levels (Dobner ct al. 1988), and then labeled for various times with
3H- Ieucine. Cytoplasmic extracts were immunoprccipitatcd wilh antiserum Rb
3 and resolved on SDS/PAGE. Figure 2-2 is an autoradiogram from an
experiment showing lhat thc proNT/N accumulatcs linearly for at least 30
minutes. Size-comparison with 35S- labeled protein markers eSlablished that
the molecular weight of thc immunoprccipitated product is approximately 17
kd (the 19.7 kd band is full- length preproNT) which corresponds to the
predicted molecular weight of proNT/N aftcr removal of the 23 amino-acid
signal peptide. Thcse experiments cstablished conditions for determining the
relative synthetic ratc of proNT/N in cells treated with different combinations
of inducers.
Figure 2- NT/N precursor peptide is synthesized in induccd PC12 cells. PC12
cells were treatcd with a combination of NGF (100 ng/ml), LiCI (20 mM),
dexamethasone (1 j.M), and forskolin (1 j.M) for 24 hours. Cells were then
washed with leucine- frec DMEM, containing dialyzed serum (10%horse and
5%fetal bovine) and induccrs. FolIowing the wash, the cells were resuspended
in the same mcdia and incubatcd for 30 minutes at 37 oc. Following the addition
of 3H- leucine (20 JlCi) at the indicated timcs, cellular extracts werc prepared
and' immunoprecipitated with eithcr prcimmunc serum (P) or antiserum Rb 
(I). The immunoprecipitated products were resolved on a SDS/polyacrylamide
gel (15%) and trcated with standard fIuorographic techniques. Truncated
crhNT RNA was translated in vitro with 35 S-meLhionine and the precipitated
proteins were run as molecular weight markcrs. The 19.7 kd protein
represents full- length crhNT.
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F and lithium do not ulate NT translation. To test whether NGF or
lithium alter the translation of thc NT/N mRNA, the above
immunoprecipitation assay was uscd to detcct proNT/N in PC12 cells that were
induced for 24 hours with various combinations of NGF, lithium
dexamethasone, and forskolin. Induced cclls werc labelcd with both 3H- leucine
and 35S- ethionine for 30 minutes and proNT/N was assayed as described
above (figure 2-2). In cells treatcd with NGF, lithium , dexamethasone, and
forskolin, the rclativc proNT/N synthetic ratcs increased 1. fold as compared
to cells treatcd with thc taILer three inducers, whereas thcrc was a 17. fold
increase whcn compared to cells lrcated with NGF, dexamethasone, and
forskolin (figure 2-3). These increases arc comparable to Increases in NT/N
mRNA levels in similarly treated PC12 cells (Table 2- 1 and Dobner et al. 1988),
suggesting that neither NGF nor lithium influences the translation of NT/N
mRNA.
Pulse-chase experiments wcre done next to examme the effect of
inducers on proNT/N processing. The initial objective was to identify
processing pathways by analysis of proteolytic intermediatcs. PC12 cells were
treated for 24 hours with NGF and/or lithium, dexamethasone, and forskolin,
and subsequently labeled for 30 minutes with 3H- leucine. Cells were washed,
resuspended in medium containing 10 mM unlabeled leucinc and the
appropriate inducers, and incubated for an additional 2, 4, and 6 hours. Cells
were harvested and cell cxtracts were analyzed by immunoprecipitation with
antiserum Rb 3. Unfortunately, proteolytic intermediates were not detected by
15% SDS/PAGE, which could only resolve protcins down to 5 kd. Therefore,
specific processing pathways could not be idcntified.
Figure 2- Synthesis of thc NT/N prccursor protein in PC12 cells treated with
various combinations of inducers. PC12 cells werc treated with the indicated
combinations of NGF (N), lithium (L), dexamcthasone (D) and forskolin (F) for
24 hours or left uninduccd (NA). Induccr concentrations were as in figure 2-
Cells were washed and incubated for 30 minutes in leucine/methionine- free
DMEM supplementcd with dialyzed serum and appropriate inducers. Following
addition of 3 H- Icucine (20 IlCi) and 35 S-mcthionine (60 IlCi) for an additional 30
minutes, cellular extracts were prepared and immunoprccipitated with either
preimmune serum (P) or Rb 3 antiserum (I). Thc immunoprecipitated products
were resolved by SDS/PAGE (15%) and processcd as described in figure 2-2. The
19.7 kd band represents full length crhNT.
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Gross altcrations in protcolytic proccssing could affect the rate of
disappearance of immunologically- dctcctable proNT/N. The half- lives for the
disappearance of immunoprecipitable proNT/N, as determined by pulse-chase
experiments in similarly induced cells, wcre esscntially thc samc: 2. 62 hours
for cells treatcd with NGF , dexamcthasone, and forskolin , 2.32 hours for cells
treated with lithium, dexamethasonc, and forskolin , and 1.97 hours for
maximally induccd cells (data not shown). Thesc results suggest that gross
alterations in proNT/N proteolytic processing or degradation do not occur. An
alternative approach to determine whethcr thcse inducers influence proNT/N
protein processing is to compare the levels of mature NT peptide with proNT/N
synthetic ratcs.
Mature ncurotensin was quantitated in PC12 cells by a radioimmuno-
assay utilizing N- or C-terminally directed anti-NT antibodics; BSA-8 and HC-
respectively (Carraway 1979; Carraway, Mitra ct al. 1991). Both of these
antibodies require 8 rcsiducs for full reaction. The antisera are highly
specific, since thcre is minimal cross-rcaction with neuromedin N and
unrelated peptides (Carraway 1979). The uscfulness of this assay for specific
quantitation of neurotensin, its metabolitcs, and processing intermediates has
been firmly established (Carraway 1979: Carraway et al. 1991). To determine
the amount of NT/N precursor protcins, PC12 cell extracts were first treated
with pepsin to rclease immunoreactive NT which was then detected using the
HC- antiserum. NT/N precursor Icvels were calculatcd by comparing the
levels of immunorcactive NT before and after pepsin treatment.
Table 2- 1 shows results of an experiment in which NT/N mRNA levels,
proNT/N synthctic rates, NT/N prccursor Icvels, and mature NT levels were
Table 2- NT/N mRNA Icvels, NT/N precursor peptide synthetic rates, and
levels of processed neurotensin pcptides in PC12 cclls trcated with different
combinations of inducers. PC12 cells were treated with the indicated
combinations of NGF (N, 100 ng/ml), lithium (L, 10 mM), dexamethasone (D , 1
11M), and forskolin (F, 111M) for 96 hours. NT/N mRNA levels were determined
by RNase protection assay using the pGEM-rNT4 probe (see Materials and
Methods).
. Quantjtation of NT/N mRNA levels was donc essentially as in figure
6. The synthetic ratcs of NT/N precursor peptide (ProNT/N) were determined
by immunoprecipitation of rpctabolically labelcd PC12 ccll extracts using Rb 3
antiserum (see Materials and Methods). C-and N-terminally processed
neurotensin peptidcs were detected by a radioimmunoassay using HC- and
BSA- antibodies, rcspcctively. NT/N precursor protein levels were determined
by comparing the levels of N-terminally detected NT in pCpSIn treated vs
untreated extracts. The amounts wcre calculatcd using NT standards and are
expressed as fmolc/106 cells. Pertinent valucs are also expresscd as a fold
increase over NOF or LOF.
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compared. In cells trcated with all four induccrs, the relative levels of NT/N
mRNA, proNT/N synthetic rates, and all NT peptides species increased in a
similar manner whcn compared to cclls treated with lithium , dexamethasone,
and, forskolin (- fold), indicating that NGF does not alter translation or
processing of proNT/N. Similarly, treatment of PC12 cells with NGF, lithium,
dexamethasone, and forskolin rcsulted in a 31. fold incrcase in NT/N mRNA
and a 21.3- fold incrcase in proNT/N synthetic rates as compared to cells treated
with NGF, dexamethasone, and forskolin, confirming that lithium does not
affect translation of NT/N mRNA. However, lithium appears to slightly inhibit
the production of mature NT as revcaled using the C- and N-terminally directed
antibodies. In maximally trcated cclls, HC- antibodies detected a 7. fold
increase in C-terminal NT, whereas only a 3. fold incrcase in N-terminal 
was observed with BSA- 8 antiserum , over cells treated with NGF
dexamethasone, and forskolin. Intcrestingly, comparison of the levels of NT/N
precursor and maturc NT suggests that NT exists predominantly in extended or
precursor forms in induced PC12 cells. In summary, these results indicate that
neither NGF nor lithium regulate the translation of NT/N mRNA. However,
lithium may have a inhibitory effect on the processing of proNT/N to yield
mature NT. Differences in PC12 cell lines or experimental conditions may
account for the discrepancies ("rom previous results which indicated that NGF
stimulated the production of mature NT (Dobncr et al. 1988). The results
presented here indicate that NT production in PC12 cells is regulated
principally at the level of NT/N mRNA accumulation.
Transcriptional Activation of thc NT/N Genc in PC12 Cells
enomic clones. The isolation and characterization of the rat gene
was instrumental in analy/, ing thc transcriptional regulation of NT/N gene
and defining signalling pathways activated by NGF and lithium. This gene was
utilized for two purposes: 1) fragments of the total rat gene were used to
optimize the dctection of nuclcar run-on transcripts, 2) antisense RNA probes
that span the first exon/intron junction of the rat gene were used to
quantitate NT/N mRNA and unspliced transcripts in induced PC12 cells by 
RNase protection assay.
genomic library was constructcd to isolatc the full length rat gene.
High molecular weight DNA was isolated from rat testes, partially digested with
Sau 3A , fractionated on a sucrose gradient and DNA in the 10 -20 kb size range
was pooled for ligation into Sam Hi digested J. EMBL4 phage arms. Ligated DNA
was packaged in vitro to yield approximately 5.5 x 106 pfu/j.g of ligated DNA.
Approximately 3.6 x 105 independent recombinants were plated and screened
using a 32P-Iabeled probe derived from the NT 8A canine NT/N cDNA clone
(Dobner et al. 1987). Thrce positive clones, rNT18, rNT19, and rNT23 were
identified and plaque purificd. Southern blot analysis using the canine cDNA
probe indicated that rNT19 containcd the entire rat NT/N precursor gene
(Kislauskis et al. 1988).
Detailed analysis of rNT19 revealed that the rat NT/N gene spans
approximately 10.2 kb of DNA. Comparison with heterologous canine and
bovine cDNAs idcnti fied the positions of three intervening sequences which
divide the mRNA scquence into four exons (figure 2-4). The sequences at
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Figure 2- Structurc of the rat neurotensin/neuromedin N gene.
The structure of the rat genomic clone (rNT19) and NT/N mRNA. In the
rat gene (upper), black boxes denote exons and thin lines denote either
introns or flanking sequences. Eco RI (E) and Hind II (H) restriction sites are
indicated. The structure of' thc gcne is projectcd onto a schematic
representation of rat NT/N mRNA (lower). Boxes represent coding sequences,
and known functional domains arc indicated by diamonds, signal sequence;
horizontal lincs, neuromedin. N- like; diagonal lines, neuromedin N; shaded,
neurotcnsin: and open, rcgions of unknown function. Two di fferent
polyadenylation sites (poly A) are indicated.

exons and introns junctions conform LO consensus splicc donor and acceptor
sequences (Padgctt ct al. 1986). Exon 1 cncodes a putative signal peptide (amino
acids 1-23). The neurotensin and neuromedin N coding domains are located in
tandem on exon 4 (amino acids 120- 169), separated only by Lys-Arg residues.
Exon 3 codes for amino acids 45- 119 and contains a scquencc similar to
neuromedin N that is precedcd by paired basic amino acids, suggesting that the
preproNT/N may be processed LO yield additional peptidcs. Exon 2 which
encodes amino acids 24- , contains no obvious functional domains.
Induct n of NT enc transcri tion in maximall stimulated P 12 c
Treatment of PCl2 cells wiLh a combinaLion of NGF, lithium , dexamethasone,
and forskolin , produces a rapid IIcrease 11 NT/N gene expression (Dobner
1988 ). Nuclear run-on transcription assays were performcd to test directly
whether these inducers alter mRNA levels by increasing the transcriptional
rate of the NT/N gcnc. At various times following treatment with all four
inducers, PCl2 nuclei were isolatcd, nasccnt transcripts wcre labeled with 32p-
UTP, and specific transcripts were dctected by hybridization to plasmid DNA
bound to nylon membranes. Figure 2-5A shows an autoradiogram of run-on
transcripts hybridized to membranes containing rat NT/N cDNA, a constitutive
positive control (a-tubulin), two inducible positive controls (c-fos and c-jun),
and pGEM- vcctor DNA as a negative control. NT/N transcripts were induced
rapidly, within 2 hours, and expression was transient, reaching maximum
levels at 4 hours. Figure 2-5B shows Lhe results of an RNase protection assay in
which NT/N mRNA was detccted in the cytoplasmic fractions, confirming that
induction resulted in increased mRNA levels in this experiment. However, the
Figure 2- Activation of NT/N gene transcription in maximally induced PC12
cells. A. PC12 cells were trcated with a combination of NGF, lithium,
dexamethasonc and forskolin (concentrations as in figure 2-2). Nuclei were
isolated from 1 x 108 cells at the indicated times, labcled with 32p- UTP, RNA was
isolated and hybridized LO /'lters containing 5 Ilg of the following plasmids; rat
NT/N cDNA (rbNT), mouse a-tubulin (MAT a 1), c- fos (pGEMfos3), mouse c-jun
(JACl.l) and pGEM 4 (see Matcrials and Methods). Thc high stringency wash
was in 0. 1 X SSC, 0. 1% SDS and 0. 1% sodium pyrophosphate at 60 oC. Run-on
transcripts were visualized by autoradiography with an intensifying screen (2
week exposure). B. NT/N mRNA was analyzcd by hybridizing the above
cytoplasmic RNAs (10 Ilg) with 32P-antisense Ell-NT riboprobc (see figure 2-
followed by digcstion with RNasc Tl and nuclease Pl. The protected products
resulting from hybridization to NT/N mRNA (169) or intcrnal standard RNA
(104) are indicated (see figure 2-6).
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level of NT/N genc transcription was low when comparcd to c-fos and c-jun.
This low level indicated that thc nuclear run-on assay could not be used to
analyze NT/N transcription in PC12 cells treated with less effective inducer
combinations. Attempts to increase the signal , such as hybridization to larger
segments of the rat gene, wcre unsuccessful. Therefore. even though nucle
run-on experiments demonstrated that the NT/N gene was transcriptionally
activated by a combination of all four induccrs, an alternative transcriptional
assay was need cd to analyze NT/N gcne cxprcssion in cclls treated with
different induccr combinations.
recursor RNA is transientl induced in thc nuclei of PC12 ell
To examine the kinctics of NT/N gene activation in detail, a RNase protection
assay was developed to monitor thc appearance of NT/N nuclear precursor
RNA using an antisense probe (Ell-NT) that spans the junction between exon
one and intron one (sec figure 2-6C). PC12 cells were treated with a
combination of NGF, lithium , forskolin , and dexamethasone for the indicated
times, and aliquots of nuclear and cytoplasmic RNA were analyzed using a 32p-
labeled El I-NT probe (figure 2-6A and B). NT/N prccursor RNAs containing
intron one (325 b protcction product) wcre clearly detectable after 2 hours,
increased to maximum Icvcls within 3- hours, and subsequently decreased in
abundance over the next 8- hours. Spliccd nuclear transcripts lacking intron
one (169 b protcction product) appeared coincidcntly with intron-containing
transcripts, but accumulated with somcwhat slowcr kinetics. Cytoplasmic NT/N
mRNA (169 b protection product) first became detectable after 2 hours and
aecumulated throughout thc 12 hour interval cxamined. These results indicate
Figure 2- RNase protection assay to monitor NT/N gene expression in PC12
cells. A. PC12 cells werc trcated with a combination of NGF, LiCl,
dexamethasone, and forskolin (conccntrations as in figure 2-2), harvested 
the indicated timc points ( 5 x I 07 cclls/time point), and both nuclear and
cytoplasmic RNA were prepared using the LiCI-urea extraction protocol. A 32p-
labeled antisense riboprobe (Ell-NT) spanning thc first splice junction was
used to dctect prccursor RNA containing intron one and processcd RNA
lacking intron one aftcr hybridization to 10 Ilg of either nuclear or
cytoplasmic RNA. Protection products were rcsolved on a scquencing gel and
visualized by autoradiography (9 days without an intensifying screen). The
protection products resulting from hybridization with either precursor (325
b) or spliced (169 b) NT/N transcripts are indicated. Hybridization with a sense
RNA standard, addcd prior to RNA extraction , resulted in a 104 b protection
product (internal control). B. Thc 169 b and 325 b protected products were
quantitated by direct scintillation counting using a Betagen model 603 blot
analyzer. The levels of intcrnal control RNA signal were used to correct for
small variations in sample recovery. Lcvels of either processed nuclear
(squares) and cytoplasmic (triangles) NT/N RNA, or precursor (circles) NT/N
transcripts are plotted using the left and right ordinate scales, respectively. C.
Schematic of the Ell-NT probe. A 489 bp Eco Rl/Dra I DNA fragment of the rat
NT/N genc was subcloncd into pGEM-4 digcsted with Eco RI and Ora I. 32p-
labeled antisense probe (E II-NT) was transcribed using T7 RNA polymerase
following linearization with Eco R 1. Sense strand RNA was transcribed with
SP6 RNA polymerase aftcr lincarization with Rsa I. The position of exon one
(striped box), intron I (opcn box), and 5' flanking scqucnces (thick line) are
indicated. The sizes of the probe and expected protection products are
indicated.
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that the NT/N gene is transienlly activatcd in maximalIy stimulated PC12 cells
over about a 10 hOll r in terv al.
The results presentcd in figure 2- demonstrate that the RNase
protection assay provides a scnsitive method for quantitating NT/N nuclear
precursor RNAs containing intron one. Threc lines of evidence strongly
indicate that increases in thc levels or NT IN prccursor RNA are principally
the result or transcriptional regulation and not changes in precursor stabilty
or processing. First, the kinetics of appearance of the 325 b product is similar
to NT/N transcripts observed in nuclear run-on assays. Second, both CAT and
luciferase reporter genes fused to rat NT/N gene cis-regulatory sequences are
regulated nearly identically to the endogenous NT/N gene when transiently
expressed in PC12 cells (Kislauskis and Dobner 1990). Third, the luciferase
fusion gene is transiently induced in maximalIy stimulated PC12 cells and the
time course of lucirerasc expressIOn closely parallels the induction of intron
one-containing NT/N precursor RNAs (Kislauskis and Dobner 1992). Since the
luciferase fusion gene contains only a limited amount of rat NT/N sequences (-
216 to +56), the transient induction of luciferase activity is likely due to the
transient transcriptional activation of the reporter gene and the instability of
both luciferase mRNA and protein in PC12 cells. Thus, the levels of intron one-
containing NT/N nuclear precursor RNAs appear to accurately reflect the
transcriptional status or thc NT/N gene.
Dif nt activation kinctics whcn NGF or lithium is used as e permi siv
indu The kinetics of NT/N gene activation in PC12 cells treated with either
NGF, lithium, or both agents, in combination with forskolin and
dexamethasonc was cxamincd next, using thc RNase protcction assay to
monitor the appearancc NT/N nuclear precursor RNA (figure 2-7). In cells
treated with NGF, dcxamcthasonc, and forskolin, intron one-containing
transcripts werc rapidly induced within 1 hour, reachcd maximum levels after
hours, and declined bclow thc limit of detcction by 8 hours (figure 2-7).
Intron-one containing transcripts werc induced for a morc prolonged period
in PC12 cells treated with lithium, dexamethasonc, and forskolin. Levels of
intron one-containing transcripts reached maximum levels by 4 hours and
subsequently dcclined to a low , steady-state levcl aftcr 12 hours, similar to the
response obscrved in cclls treated with all four inducers (figure 2- 6). NT/N
transcripts wcre not dctected in cells trcated with forskolin and
dexamethasone (data not shown), consistent with previous evidence that the
permissive induccrs, NGF or lithium, are requircd for activation (Dobner,
Tischler et a1. 1988: Kislauskis and Dobner 1990). Thc distinct induction
kinetics obscrved when cells were stimulated with combinations of either NGF
or lithium , forskolin, and dexamethasone provided a preliminary indication
that the responscs involved distinct signalling mechanisms.
Figure 2- Differential lime course of NT/N gene activation when either NGF
or lithium is used as the permlsslvc agent. A. PC12 cells (- 5x 107 cells/time
point) were treated with all four inducers (NLDF), NGF, dexamethasone, and
forskolin (NDF), or lithium , dexamethasone, and forskolin (LDF) at the
concentrations shown in figure 2-2. At the indicated times, nuclear RNA was
isolated and 20 Ilg analyzed in an RNase protection assay using the El I-
probe as described in figure 2-6. The protection products resulting from
hybridization with either precursor (325 b) or spliced (169 b) NT/N transcripts
are indicated. Hybridization with internal control RNA resulted in a 104 b
protection product. A control reaction was performed by hybridizing the
probe with 10 Ilg yeast RNA (lane Y). Radiolabeled RNA markers are shown
(M). B. graph representing three independent experiments. PC12 cells were
treated with either NGF (opcn circles), lithium (open triangles), or both
inducers (solid circles), in combination with dexamethasone and forskolin, for
the indicated times, and levels of intron one-containing NT/N nuclear
precursor RNAs werc quantitated as in figure 2-6. The levels of 325 b
protection product (cpm of 325 b protection product/llg input total nuclear
RNA) are plotted using the lefthand scale for maximally induced cells and the
righthand scale for. ceIls treatcd with either NGF or lithium , in combination
with dexamethasone and forskolin. Error bars represent the standard error of
the mean for the 2, 4 , and 6 hour time points (n=3) or the range for the 1 and 8
hour time point (n=2).
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Processing and Transport of NT/N mRNA
As discussed above, thc RNase protection assay appears to accurately
reflect the transcriptional status of the NT/N gcne. Quantitative analysis of
intron one-containing nuclear RNAs, and both nuclear and cytoplasmic RNAs
lacking jntron one has provided an indication that thcre are no major
differences in either the splicing of intron one, or the transport of processed
NT/N RNA to the cytoplasm in cells treated with differcnt combinations of
inducers. Thc 169 b protected fragment represents the processed NT/N RNA , at
least at thc level of splicing of intron 1. Greater than 90% of the NT/N RNA,
after correcting for differences in protected fragment sizcs , is spliced at the
intron one junction and rapidly accumulates in the nucleus (figure 2-6).
Processed NT/N RNA appcared in the cytoplasm following the appearance of
nuclear NT/N RNA. In othcr expcrimcnts in which processed NT/N was assayed
at more frequcnt intervals (data not shown), the appearancc of NT/N RNA in
the cytoplasm lagged behind that of nuclear processcd NT/N RNA by
approximately 30 minutes. At later lime points, i.e., 12 hours, the cytoplasmic
fraction is about 75% of the total NT/N RNA. These results are consistent with
the NT/N primary transcript being rapidly spliced, followed by transport of
mature NT/N mRNA to the cytoplasm within about 30 minutcs.
To asscss the impact of these induccrs on splicing of intron one,
processed NT/N RNA was analyzed in cells induced with NGF and/or lithium in
combination with dcxamethasonc and I'orskolin by RNase protection with ElI-
NT as a probc. The processed NT/N RNA in the nucleus of cells treated with NGF,
dexamethasone and forskolin showed a kinetic pattern similar to that of intron
one-containing transcripts; rapidly appearing at 1 hour, peaking at 2 hours
and declining to minimal levels by 12 hours (figure 2-7A). Similarly, in cells
treated with lithium, dexamethasone, and forskolin , processed NT/N RNA was
first observed at 2 hours, rcaching maximum lcvcls by 6 hours and returning
to a non-zero basal Icvcl by 12 hours (figurc 2-7 A). No differences were
observed in the ratio of precursor NT/N RNA to processed NT/N RNA (intron
one spliced out) in thc nucleus at thc time of peak precursor NT/N RNA
expression in cells trcated with di fferent inducer combinations (figure 2- 8A).
In all threc conditions thc proccssed RNA was betwcen 90-95% of the total
NT/N RNA in the nuclcus. Togcther, thesc results indicate that NGF and lithium
have no major cffect on splicing of thc NT/N RNA transcript, at least at the
intron 1 junction , although di/'crential splicing at thc other exon- intron
junctions cannot be rulcd out.
Similar studies were done to analyze the effect of NGF and lithium , in
combination with dexamethasone and forskolin , on thc accumulation of
cytoplasmic NT/N mRNA. In all cases, the delaycd appearance of NT/N mRNA in
the cytoplasm was similar to that of the appearance of nuclear processed NT/N
RNA. In cells trcatcd with NGF, dcxamethasonc, and forskolin, cytoplasmic
NT/N mRNA accumulated rapidly, first appcaring at about 2 hours, and
reaching maximum Icvels by 4 hours (data not shown). In contrast,
cytoplasmic NT/N mRNA first appearcd 4-6 hours post-induction in cells
treated with lithium, dexamethasonc, and forskolin and accumulated
continuously for up to 12 hours (data not shown). These results suggest that
the spliced NT/N RNA is bcing efficiently transported out of the nucleus and
that NGF and lithium do not alter the expected pattcrn of accumulation within
Figure 2- NGF and lithium do not alter NT/N RNA splicing or transport into
the cytoplasm. A. A histogram showing the pcrcent of total nuclear RNA that
is processed (spliced at thc exon l- intron 1 junction) in PC12 cells treated with
all four inducers (NLDF), NGF, dexamcthasone, and forskolin (NDF), or lithium,
dexamethasone, and forskolin (LDF) for 4 , 2, and 6 hours, rcspcetively. The
number of experiments used to detcrmine thesc values is shown in the open
boxes. The error bars rcprcsenl the standard error of the mean (SEM). Missing
error bars indicate that thc SEM was extrcmely small. B. A histogram showing
the percent of total processed NT/N RNA that is found in the cytoplasm of PC12
cells treated with NLDF, NDF , or LDF for 12 hours. The numbcr of experiments
used to determinc thcse values is shown in the open boxes. Thc error bars
represent the S EM as desc ri bed in A.
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the cytoplasm. The levcls of processcd NT/N RNA in the nucleus were
compared with levcls in the cytoplasm to support this conclusion (figure 2-
8B). For all threc conditions, approximately 75% of thc total processed NT/N
RNA was found in thc cytoplasm , aftcr 12 hours of induction. Furthermore, the
levels of processcd NT/N RNA in the cytoplasm , at twelve hours, mimics NT/N
mRNA in similarly induced cells, dctectcd by using an exon four probe (Table
1). Taken togethcr, these rcsults indicate that NGF and lithium do not alter
the splicing of the NT/N primary transcript or mechanisms controlling the
accumulation of NT/N mRNA within the cytoplasm, such as transport.
The appcarancc of the two extra protectcd fragmcnts, approximately 190
and 196 nucleotidcs in lcngth was unexpected (figure 2-9). One possible
explanation for thc appearancc of thcse bands is that alternate transcriptional
start sites are being used resulting in NT/N mRNA that is extended 5' of the
defined CAP site. Another possibility is that alternative splicing produces NT/N
RNA with extra intron scqucnces. An RNase protcction assay utilizing
truncated Ell-NT probes (l"gure 2-9A) was used to distinguish between these
two possibilities. Thc Hae III probe is truncated just 3' of the predicted
alternative start sitcs while thc Ava II probe is truncated within exon 1. If
alternative start sites are utilized, thcn only one fragment should be observed,
whereas if alternativc splicing occurs, thcn all thrce of these fragments wil
be detected by both probes. As shown in figurc 2-8 B, three processed
fragments were detccted utilizing each of thc probes. This suggests that the
NT/N primary transcript is diffcrentially spliced at the junction between exon
1 and intron 1, even though thc possibility that the cxtended protection
products are artifacts rcsulting from the probc cannot be ruled out.
Figure 2- NT/N mRNA is differentiaIly spliced at the exon l- intron 1
junction. A. Probes uscd to identify the extended proccssed NT/N RNA
fragments. pGEM Ell-NT was linearized at Eco RI , Hae Il. or Ava II sites and
transcribed with T7 RNA polymcrase as described in figurc 6. The total probe
length (probe), precursor NT/N fragment (unspliced), and processed NT/N
fragment (spliced) are shown for each probe. The predicted extension sites are
indicated by arrows, either 5' of start site (A) or 3' of exon l-intron 1 junction
(B). B. RNase protcction gel of 10 j.g of nuclear (N) and cytoplasmic (C) RNA
from fully induccd (NLOF) PC12 cells. 10 j.g of poly A + and A- fractions of
cytoplasmic RNA were also tested. Undigcsted probes are shown; Eco RI (E), Hae
II (H), or Ava II (A). Thc unspliced (325 or 254) and spliced (169 or 95)
protected fragmcnts are indicated. Fragment sizes were determined from a
standard curve of the radiolabeled RNA markers (M). C. The nucleotide and
predicted amino acid sequencc of the area surrounding the exon l-intron 1
junction. The authentic (1) and prcdicted (2, 3) spliced donor sites are
indicated.
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Inspection of the sequences surrounding thc exonl- intron boundary (figure
9C) identified two potential splice donor sitcs (sites 2+3) that could generate
transcripts that would yield thesc 190 b and 194 b protection fragments. Splice
donor sites 2 and are 66 and 44 pcrcent idcntical , respcctively, to the
consensus splice donor site. However, both of these are located 3' to an in-
frame termination codon , indicating that neither of these thcse splicing
events would producc functional peptides. these alternativelyInterestingly,
spliced NT/N RNAs werc not isolatcd as poly A + RNA. Further experiments need
to be done to determinc if thc lack of polyadenylation correlates with the
production of the putative alternativcly spliced RNAs.
In summary, the results prescntcd in this chapter have shown that the
NT/N gcne is primarily regulated at the level of transcription, and that
alterations in peptide processing playing a mITor rolc in controlling NT
production in PC12 cclls. NGF and lithium in combination with dexamethasone
and forskolin rapidly induce NT/N gcne expression, although with distinct
kinetics. Thc kinetics of activation are consistcnt with a role for AP-
complexes in controlling NT/N gene cxprcssion leading to the prediction that
de novo synthesis of AP- proteins is requircd for NT/N gene activation.
CHAPTER III
PROTEIN SYNTHESIS INHIBITORS HAVE DIFFERENT
EFFECTS ON NT/N GENE TRANSCRIPTION
AP- l genes cncode transcription factors that couple cxtracellular stimuli to
alterations in target gcnc expression. AP- factors intcract with cis-acting
elements locatcd within regulatory regions of target gcnes thcreby altering
the transcriptional state of thcse gcncs (Shcng and Greenbcrg 1990; Curran
and Morgan 1987). NGF rapidly induccs thc expression of several proto-
oncogenes, including those that cncode AP- factors (Sheng and Greenberg
1990). Several lines of cvidence have implicated AP- l complexcs as mediators
of the permissive effects of NGF and lithium on NT/N gene transcription: 
the NT/N promotcr contains a functional AP- site (Kislauskis and Dobner
1992), 2) as shown in the prcvious chapter , the NT/N gene is transiently
activated with kinetics consistcnt with the induction of AP- l genes (Bartel et
al. 1989), 3) NGF and lithium selectivcly activated rcporter genes driven by
consensus AP- sitcs (Dobncr et al 1992) and, 4) various combinations of
bacterially produccd AP- factors bind as hcterodimers to the NT/N AP- site,
in vitro (G. McNeil and P. Dobner, unpublishcd results). Expcriments described
in this chapter were designcd to determine whether de novo protein synthesis
is required for the transicnt activation of the NT/N gene. Such a requirement
would be consistent with a role for induced AP- factors in the activation of
NT/N transcription. PC12 cells wcrc prc-trcatcd with protein synthesis
inhibitors prior to treatment with different combinations of NGF, lithium,
dexamethasone and forskolin, and Icvels of intron one-containing transcripts
. were quantitated to asscss transcriptional changes. The results from
experiments rcported in this chapter demonstrate that the permissive effect of
NGF and lithium on NT/N genc cxpression in PC12 cells involves both the
induction and post-translational modification of signalling proteins,
presumably AP- factors.
cloheximide and anisom cin cfficicntl inhibit rolcin s nthesis in PC12
To assess thc requircment for newly synthcsized protcins in regulating
NT/N gene expression, PC12 cells were treated with the protein synthesis
inhibitors, cycloheximide and anisomycin. Both these drugs inhibit protein
synthesis, to greater than 95% , in eukaryotic cells without seriously affecting
RNA synthcsis (McKnight 1978; J imcncz and Vazquez 1979). Anisomycin binds
to both thc acceptor and donor sitcs of 60 ribosomal subunits thus inhibiting
peptide bond formation (Jimencz and Vazquez 1979). Cyclohcximide blocks
translocation of pcptidyl-tRNA from thc ribosomal acc ptor site to the donor
site (Gale et al. 1981). To asscss thc efficiency of thesc drugs, PC12 cclls were
treated with either anisomycin (50 I-M) or cycloheximide (10 I-g/ml) for
various times and protein synthesis, RNA synthcsis, and viability were
quantitated. Protein synthesis inhibition was examined by comparing the
incorporation of 35S- thioninc into lrichloroacetic acid - prcc i pi table
proteins, in treated and untreated cclls. As shown in figure 3- , both drugs
inhibited protein synthesis to maximum levels within 2 hours. Grcater than
97% inhibition was achieved with anisomycin whcreas approximately 95%
inhibition was observed with cycloheximide. These lcvels of protein synthesis
were sustained throughout thc twelve hour coursc of the expcriment and are
consistent with results reported by Grccnberg et ai., who showed that
anisomycin was a more stringent inhibitor of protein synthesis in PC12 cells
(Greenberg ct 1986). Further expcriments
Figure 3- Protein synthesis in PC12 cclls is efficicntly inhibited by
anisomycin and cycloheximidc. PC12 cells were treated with either 50 11M
anisomycin (solid symbols and brokcn lincs) or 10 J.g/ml cycloheximide (open
symbols and solid lines). Cells werc harvestcd at vanous times and protein
synthesis (circles), RNA synthcsis (squarcs) and cell viability (triangles) were
determined as dcscribcd in Material and Methods. Thc values arc represented
as percent of untreated cells at each timc point.
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showed that anisomycin was just as effectivc within 15 minutes of addition
(data not shown). Incorporation of 3 H-uridine into acid- precipi table material
was used to examinc the effects of thc inhibitors on RNA synthesis. Acid
precipitable counts were compared to total cellular counts to corrcct for
differences in uridinc uptake, since a marked inhibition of uridine uptake, by
protein synthesis inhibitors, was previously demonstratcd chick oviduct
explant cultures (McKnight 1978). Both anisomycin and cycloheximide
reduced the levels RNA synthcsis approximately 40%, within hours
treatment, which was then sustained at that levcl for the duration of the
experiment (figure 3- 1). Neithcr agcnt affccted ccll viability, as determined by
trypan blue cxclusion , during thc firs! 8 hours of trcatmcnt (figure 3- 1),
although a slight dccreasc in viability was obscrved aftcr 12 hours. These
results demonstratc that both drugs ef/'ciently inhibit protein synthesis in
PCl2 cells, anisomycin being slightly more effcctive than cycloheximide,
while only having a small effect of RNA synthcsis and cell viability.
Anis cin and c clohcximidc allenuatc NT cne activation in maximall
imulated cells To determinc whether NT/N gene activation requires ongoing
protein synthcsis, PC12 cells werc pre- treated with either cycloheximide (10
Ilg/ml) or anisomycin (50 11M) for 30 min followcd by treatment with a
combination of NGF, lithium, dcxamethasone, and forskolin in the continued
presence of the inhibitors. Cells were harvested at the indicated times after
induction and intron onc-containing transcripts were quantitatcd using the
RNase protection assay. Figure 3-2A shows that treatment with either inhibitor
markedly attenuated NT/N gcnc activation, anisomycin having a greater effect
Figure 3- Effects of protein synthcsis inhibitors on NT/N gene activation.
A. PC12 cells were prc-treatcd with eithcr cycloheximidc (10 Ilg/ml, solid
squares), anisomycin (50 IlM, solid circles), or no inhibitor (open circles) for
30 min , prior to induction with a combination of NGF, lithium , dexamethasone,
and forskolin. Cells were harvestcd at thc indicatcd times following induction
nuclear RNA was isolatcd, and aliquots (25 Ilg) werc used to quantitate levels of
intron one-containing NT/N nuclear precursor RNAs (325 b product) as in
figure 2-6. The graph represents a single experimcnt. B. Control PC12 cells
(open circles) or cclls that had bcen pre- treated with 50 IlM anisomycin for 0.
(solid circlcs) or 2 hr (solid squarcs) wcrc treated with NGF, forskolin , and
dexamethasonc in the continucd prcsence of anisomycin and harvested at the
indicated times. Nuclear RNA (25 Ilg) was analyzed as described above. C. As in
B, except control PC12 cells (open circles) or cells pre-treated with anisomycin
for 30 min (solid circlcs) werc subsequcntly stimulatcd with lithium, forskolin,
and dexamethasonc. D. Autoradiogram of a sequencing gcl (8M urea/6%PAGE)
used to quantitatc levels of thc 325 protection product in thc experiment
depicted in panel B. The posilions of thc 325, 169 and 104 b protection products
resultng from hybridization to NT/N nuclear RNAs containing or lacking
intron one and sense RNA standard RNA, rcspectively, are indicated. Nuclear
RNA from untreated cells (NA) or yeast RNA (Y) were also probed. The length
of anisomycin pre- treatment (A 0.5, 30 min; A 2 , 2 hr) and thc induction times
(hr) are indicated above thc gel.
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than cycloheximide. This is consislent with anisomycin bcing a more
stringent inhibitor of protein synthesis than cycloheximidc in PC12 cells.
However, neilhcr inhibitor complclcly abrogated exprcssion indicating that
post- translalional mcchanisms arc also involved in activating the NT/N gene
within maximally stimulated cells, although the limitcd amount of residual
protein synthesis may be sufficient for activation.
Anis cin attcnuatcs res onses involvin lithium but not N Similar
experiments were performed in cells trcated with eilher NGF or lithium , in
combination with dexamethasonc and forskol in (fi gu res 3 - 28 - D). Surprisingly,
anisomycin pre- treatmenl had no crfcct on the initial activation of NT/N gene
expression in cells treatcd with a combination of NGF, dcxamethasone, and
forskolin although prolonged the appearance ofanisomycin prc-treatment
intron one-containing transcripls in these cells (figurcs 3-28 and D). Longer
pre-treatment with anisomycin (2 hr) had essentially the same effect on NT/N
gene activation (figures 3-28 and 0). Thesc rcsults indicate that newly
synthesized proteins are not requircd for NT/N gene activation by NGF
forskolin, and dexamethasone, but are require for subsequent down-
regulation. In contrast, ncw protcin synlhesis is required for the initial
activation phase in cells lrcatcd with lithium, forskolin , and dexamethasone
(figure 3-2C). The latcr stable phase of activation was not affected, even when
the inhibitors were prescnt for up lO 48 hours (data not shown). These results
taken together indicate that NGF and lithium inOuence NT/N gene expression
through distinct permissivc their requirementspathways, distinguishcd
for ongoing protcin synthesis.
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NGF and lithium induce AP- ene ex rcsslOn. The requircmcnt for protein
synthesis in the rcsponse to lithium on NT/N genc cxprcssion suggests that
lithium may bc acting through ncwly synthcsized factors. To examine how
lithium influcnces AP- aClivity, thc expression of the scvcn characterized
AP- l genes was analyzed in PC 12 cells treatcd wi th di f('erent inducer
combinations (figurc 3-6). RNA blot analysis dcmonstrated that NGF treatment
resulted in thc rapid, transient induction of c-fos, fra- 1, c-jun, and jun- gene
expression as expected (I to et al. 1990; Bartel et al 1989), and had a similar
effect on fos gcne cxpression. Trcatmcnt with NGF, forskolin, and
dexamethasonc enhanced c-fos, fos Band jun- gcne expression. NGF had no
effect on jun- and fra- genc cxpression under any circumstance. The c-jun,
jun-D, fra- and fra- gcncs wcre cxprcssed at dctectable levels in
unstimulated PC12 cells and thus post- translational regulation of these AP-
proteins could be involved in thc protcin synthesis indcpendent activation of
NT/N gene cxpression in responsc to NGF, dcxamethasonc, and forskolin.
Lithium had distinct effects on AP- 1 gcnc exprcssion eithcr alone or 
combination with dexamclhasonc and forskolin (figure 3-6). A particularly
interesting effcct was the dclaycd activation of c-jun and fra- gene
expression in rcsponse to lithium. This selective cffect opens the intriguing
possibility that lithium influences NT/N genc exprcssIOn as a consequence 
the delayed induction of c-Jun/Fra- 1 complexes.
Ani cin and c cloheximidc do not induce NT transcri tion.
I The prolongcd response to NGF, dcxamethasone, and forskolin observed in
anisomycin-treated cells newly synthcsized jnh i bi tory factorssuggcslS lhal
Figure 3- Induction of AP- I gene expression in PC12 cells. PCl2 cells were
treated with thc indidlted combinalions or inducers and cclls were harvested
at the indicatcd timcs. Total RNA was extracted, and AP- l gene expression was
analyzed by RNA bloLling using 32 P- labeled probes prepared using the
indicated AP- l cDNA cloncs as described in Materials and Methods. The filters
were washed and AP- I mRNAs wcre visualized by autoradiography with an
intensifying scrcen. Exposure limcs: c-fos, fos- and jun- 24 hours; c-jun, 
hours; jun-D, fra- and fra- wecks. Induccr abbreviations are as follows
NGF (N), lithium (L), dexamethasonc (D) and forskolin (F). Inducer
concentrations arc as in figure 2-
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may rapidly attenuatc NT/N gene transcription. Howcvcr anisomycin could
act by dircctly inducing thc NT/N gcne or potentiating the effccts of
dexamethasone and forskolin. Mahadevan and collcagucs showed that
anisomycin , at concentrations bclow those required to inhibit protein
synthesis, was ablc to stimulate intracellular signalling rcsulting in the
specific phosphorylation of chromatin and the induction of c-fos and c-jun
mRNA in fibroblasts (Mahadevan and Edwards 1991). To rule out this
possibility, cells wcre treated with cither anisomycin (50 M) or cycloheximide
(10 g/ml) alone or in combination with dexamethasonc and forskolin. In all
cases, nei ther drug inrIuenced the levels of intron onc-containing transcripts
during a 12 hour pcriod (data not shown). Thercforc, thesc drugs do not induce
NT/N gene expression alone or in combination with dexamcthasone and
forskol in.
To further support thc rolc of protein synthesis inhibition in the
perpetuatiqn of the NGF phase in anisolllycin trcated cells, an experiment was
performed by pre-treating PC12 cells with both anisomycin and cycloheximide
for 30 minutcs, at various conccntrations, prior to induction with NGF
dexamethasone, and forskolin. Cells wcre harvcsted at 4 hours post- induction,
and intron one-containing transcripts were analyzed by RNase protection. As
shown in figure 3-4A, maximum levcls of intron one-containing transcripts
were observed in cclls treated with 0. 5 to 5. anisomycin and 0. 1 to 1.0
g/ml cycloheximidc, that inhibited protein synthesis by 80-concen trat ions
90% (figure 3-48). No effect on thc levels of intron one-containing transcripts
was seen in cclls treatcd with inhibitor concentrations that had little effect 
protein synthesis (0. 005 anisomycin and 0. 001 g/ml cycloheximide). Taken
Figure 3- Correlation betwecn protein synthesis inhibition and prolonged
activation of the NT/N gene by NGF. dexamethasone, and forskolin. A. RNase
protection assay used to quantitate thc levels of the 325 protection product
in an expcriment in which PC12 cells wcre pre-treated for 30 minutes with
various concentrations or cithcr anlsomycll or cycloheximide prior to
induction for 4 hours with NGF, dcxamethasone, and forskolin. Thc positions of
the 325, 169 and 104 b protection products resulting from hybridization to
NT/N nuclear RNAs containing or lacking intron one and scnse RNA
standards, respcctively, are indicatcd. Nuclear RNA from untreated cells (NA)
or yeast RNA (Y) werc also probed. Concentrations of anisomycin (11M) and
cycloheximide (l1g/ml) arc indicated above the gel. Radiolabclcd RNA markers
(M) are shown. B. A graph reprcscnting the levels of protcin synthesis at
various concentrations of anisomycin (11M. open circles) and cycloheximide
l1g/ml, closed circles). Values on the y-axis are represented as percent of
untreated cclls.
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together these results demonsLraLe LhaL perpetuation of the response to NGF,
dexamcthasonc, and forskolin in anisomycin-treLlted cells is not due to an
inductive effcct of thc drug but is associated with the inhibition of protein
synthesis.
Anis in does not inhibit RNA s licin Thc prolonged response to NGF
dexamethasone, and forskolin could also be duc to the inhibition of NT/N
mRNA splicing. To rule out the possibility that this effcct was due to a general
inhibition of splicing in anisomycin-treated cells, a-tubulin transcripts were
analyzed using a riboprobe (figure 3-5A) that spanned the junction between
intron 3 and exon 4 of the A T14 a-tubulin gene (Lemischka and Sharp 1982).
An RNase protcction assay was performed using the same RNA samples as those
in figure 3-20 and unspliccd RNA (562 b protected fragment) was compared to
spliced RNA (383 b protccted fragmcnt). However, other bands, approximately
470 and 300 nucleotides in length , werc also detected whcn PC12 RNA was
analyzed. The 470 b band seems to result from alternatively spliced a-tubulin
RNA, Sllce a near perfcct consensus splice acceptor site is located within
intron 3, 80 nucleotides 5' of the authentic acccptor site (Lemischka and Sharp
1982). A group of bands around 300 nuclcotides probably represents identical
sequences within gencs coding for other rat a-tubulin isotypes, since this
region is highly conscrved between various mouse and human a-tubulin
isotypes (Villasantc et al. 1986). As shown in figure 3-48, anisomycin
treatment did not alter the relative abundance of a-tubulin nuclear RNAs
I containing or lacking intron 3 or the alternatively spliced products. Similar
results werc obtained from cells pre- treated with eithcr anisomycin or
Figure 3- Anisomycin docs not alter the splicing of a- tubulin mRNA.
A. A schematic of the rat a- tubulin genc (AT14) and riboprobe used to detect
precursor and spliced a-tubulin mRNA. An Eco RI fragment containing intron
(13) and part of cxon 4 was subcloncd into pGEM 4. Transcription with SP6
RNA polymcrase after linearization with Hind III produccs a 576 nucleotide
antisense riboprobe. Thc expccted protcctcd fragments resulting from
hybridization to jntron thrcc-containing (562 b ) prccursor RNA or spliced
RNA lacking intron three (383 b ). Thc prcdictcd alternative splice acceptor
site is denoted by an asterisk. B. Autoradiogram showing a RNase protection
experiment in which thc a- tubulin probe was hybridized to thc same RNAs (5
g) used in the expcriment shown in figure 2-3 D. Thc unspliced (562) and
spliced (383) fragmcnts are indicatcd. The 470 b band reprcscnts alternatively
spliced mRNA, whercas homologous regions of other a- tubulin isotypes protect
fragments of approximately 300 b (sec tcxt). Nuclear RNA from untreated cells
(NA) or yeast RNA (Y) were also probed. The length of anisomycin pre-
treatment (A 0.5, 30 min; A 2 , 2 hr) and the induction times (hr) are indicated
above the gcl.
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cyclohcximide pnor to lrcatmCI1 \vith lilhium, dexamclhasone, and forskolin
or with all four induccrs (dala nol shown). This rcsult demonstrates that
anisomycin trcatmcnt does not inhibit gcneral splicing mechanisms. These
results arc thosc demonstrating that cyclohcximidc treatmentconsistcnt with
of HeLa cclls for up to 6 hr docs not inhibit mRNA splicing (Zeitlin et al. 1987).
Comparative analysis of the levels of precursor and spliced NT/N transcripts in
treated PCl2 cclls reinforce thcsc rcsults. In all experiments analyzed, neither
anisomycin nor cycloheximide alter thc relative amounts of NT/N RNAs in the
nucleus of cclls induced with NGF and/or lithium in combination with
dexamethasone and forskolin. Takcn together. these rcsults support the
conclusion that anisolllycin does not inhibit the splicing of the NT/N primary
transcript, at least al thc exon onc- inlron one junction.
Differential cffects of c clohcximidc on NT cne ex ressIon. To determine
if the less stringcnt prolein synthcsis inhibilor had effeCls similar to
anisomycin on NT/N gcnc cxpreSSlOn , cxperimcnts were performcd in PC12
cells treated with cyclohcximidc prior to induction with NGF or lithium in
combination with dexamethasone and forskolin. Consistent with results
obtained using anisomycin , cyclohcximide did not attenuate responses to NGF,
dexamethasone, prc-trcatment withrorskol in.and Furthcrmorc,
cycloheximidc resulted in prolonged activation of NT/N gene expression after
induction with a combination of thcse threc induccrs (data not shown). These
results support the conclusion thai newly synthesized proteins are not
required for NT/N gene activation by NGF , forskolin, and dexamethasone, but
are required do wn - regu I ation.for subsequent
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Surprisingly, cycloheximide potentiated the response to lithium,
dexamethasone, and forskolin. Figurc 3-6 shows an cxperimcnt in which PC12
cells werc treated with cyclohcximidc (10Ilg/ml) prior to induction with
lithium, dexamcthasonc and forskolin, The levels of intron one-containing
transcripts were highcr in cells trcated with cyclohcximide than in untreated
cells. It is unclear why cycloheximide had thc opposite effcct than anisomycin
on the response to lithium , dexamethasone and forskolin , since it would be
predicted that cycloheximidc would allenuate this responsc similar to
anisomycin, although not to the same degree. Thcse results suggest that
cycloheximide may be activating or inducing factors that increase NT/N gene
expression. However, this cannot be a dircct effect sincc cycloheximide had no
effect on NT/N transcription alone or in combination with dexamethasone and
forskolin (sce above). One possible explanation that would account for these
results relics on the fact that protcin synthesis inhibitors cause a super-
induction of immediate early gene expression , especially AP- 1 genes (Ryder 
aI. 1988: Greenberg et a!. 1986; Herschman 1991). If protein synthesis is not
maximally inhibited , as in this case of cells treatcd with cycloheximide, the
super-induced levels of AP- 1 mRNA could be translated and higher than
expected levels of AP- factors would be obtained. ldentirication of the AP-
genes induced by lithium will be necessary before further experiments can 
designed to address this discrepancy between anisomycin and cycloheximide.
Figure 3- Cycloheximide accentuates the rcsponsc to lithium, dexamethasone
and forskolin. Analysis of" prccursor NT/N RNA in an cxperimcnt where PC12
cells werc treated with 10 Il. g/ml cycloheximide (closed circles) or left
untreated (opcn circles) prior to induction with lithium, dexamethasone, and
forskolin. At the indicatcd times, cclls werc harvested and the 325 protected
fragment was quantitated by RNase protcction as described in figure 2-
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CHAPTER IV
NGF AND LITHIUM ACTIVATE DISTINCT SIGNALLING
PATHW A YS REQUIRED FOR NT/N GENE EXPRESSION
The previous two chapters presented evidcnce that the permissive
agents NGF and lithium, in combination with dexamcthasone and forskolin,
rapidly and transiently activate NT/N gene transcription , although exhibiting
different kinetics and requirements for protein synthesis. The effect of these
inducers are likely to be mediated through either the induction or
modification of AP- factors. In this chapter three questions are addressed: 1)
are separatc or common signalling componenls mediating the effects of NGF
and lithium, 2) are the signal transduction pathways activated by lithium
available in NGF-diffcrentiated PC12 cells, and 3) is thc activation of protein
kinase C (PKC) required for the induction of NT/N transcription? The results of
experiments described in this chapter show that NGF and lithium activate
distinct signalling pathways required for NT/N transcription in PC12 cells. The
pathway idcntified by lithium is present in neuronally-differcntiated PCl2
cells and does not require PKC to influence NT/N gene expression.
and lithium act throu distinci nallin
g p
athwa The transient
induction of NT/N gene expression in responsc to different inducer
combinations suggestcd thai pre- Ircatment of PC12 cells with cither NGF or
lithium might block subsequent responses to induccr combinations and could
be used to furthcr distinguish the underlying pathways. For instance, pre-
treatment with lithium could triggcr the transient induction of a required
activator protein(s), but would nOl activate NT/N gene exprcssion in the
absence of other induccrs. The addition of forskolin and dexamethasone
I following lithium pre-treatment would also bc inel'fective due to the absence
of the transicntly cxprcssed lithium-regulated component. Similarly, NGF pre-
treatment could induce the cxprcssion of a protein(s) involved in down-
regulating NT/N gene exprcssion blocking subsequent activation by a
combination of NGF, forskolin, and dcxamethasone. If the mechanisms of
activation and inactivation arc difrcrcnt for cach inducer combination as 
suggested by the anisomycin desc ri bed above, then pre- treatmentexperiments
with NGF would not be cxpectcd to block subsequcnt activation by lithium,
forskolin, and dexamethasone and vice versa.
To cxamine the cI'fccts of prc-treatment on subsequent NT/N gene
activation, PC12 cclls were treated with cither NGF or lithium for 12 hours
prior to stimulation with di fferent induccr combinations (figure 4- 1). Initial
experiments demonstrated itself did not induce NT/N genethai prc-trcatment
expression (data not shown). Prc- trcatmcnt with NGF blocked subsequent NT/N
gene activation 11 rcsponsc to combincd trcatmcnt with NGF, forskolin, and
dexamethasone, but did not block thc rcsponsc to lithium, forskolin , and
dexamethasone. was observed after lithium pre-treatment,The rcversc pallcrn
indicating that distinct signalling components are utilized by NGF and lithium.
Interestingly, both NGF and lithium pre-treatment affectcd the kinetics and
magnitude of subsequent NT/N gcnc activation (figure 4- 1). Pre-treatment
with lithium for 12 hours prolongcd subsequcnt NT/N gene activation by NGF,
dexamethasonc, and implying that lithium influcnces the pathwayforskolin,
controlling down-rcgulation of thc rcsponse to NGF, forskolin , and
dexamethasone, pcrhaps ovcrriding it. In addition , lithium , dexamethasone,
and forskolin significantly stimulated NT/N gene expression after NGF pre-
'treatment. These results indicatc thai NGF and lithium activate distinct
signalling pathways rcquircd for NT/N gene cxpression , although there also
Figure 4- Effects of prc-treatmcnt with cither NGF or lithium for 12 hours on
NT/N gene activation. PC12 cclls wcrc pre-treatcd with cithcr NGF (N) or LiCI
(L) for 12 hours, or lert untrcated (-), and subsequcntly induced with either
NGF or lithium, in combination with dexamethasonc and forskolin , for the
indicated times. PC12 cells were also stimulated with a combination 
dexamethasone and rorskolin as control. Nuclcar RNA (25 j.g) from each time
point was analyzed using thc RNasc protection assay describcd in figure 2-
Protected products were rcsolved on a sequencing gel and visualized by
autoradiography (5 days) with an intensi fying screcn. The positions of the
325, 169, and 104 b protection products are indicated. Lanes containing 3 2p-
labeled RNA markers and the products or a protection reaction in which 25 j.g
of yeast RNA was hybridized with the 32P- labeled Ell-NT probe (lane Y) are
shown. Prc-treatmcnt and induction conditions are indicated abovc the
autoradiogram using the rollowing inducer abbreviations: NGF, N; lithium, L;
forskolin, F; and dcxamethasone, D. The inducers werc used at the same
concentrations as dcscribed in Fig. 2-
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appears to bc some cross- talk between pathways.
The ermissive a ents NGF and lithium are active in NGF di ffcrentiated PC12
cells. Long- term NGF treatmcnt causes PC12 ceIls to convert from an adrenal
chromaffin- like to a sympathetic neuronal phcnotypc (Greenc 1978; Greene
and Tischler 1982). PC12 cells dif"ferentiated with NGF have been used
extensivcly to investigate transcriptional control mechanisms involved in the
expression of neuron-speci fic genes (Dobncr et al. 1988; Gizang-Ginsberg and
Ziff 1990; Kislauskis and Dobner 1990). If cither NGF or lithium arc active in
neuronally-differentiated PC12 cells, then the signalling pathways mediating
their effect are likcly to bc availablc in post-mitotic neurons and could be
important for neuronal signall ing.
The ability of lithium to cooperatively activate NT/N gcne expression in
PC12 celIs that had been exposcd to NGF for 12 hours (sec figure 4- 1) suggested
that this pathway may be available in NGF-dif"ferentiated PC12 cells. To test this
hypothesis, PC12 cells that were treated with NGF for 10 days or left untreated
were subsequently stimulatcd with either lithium or NGF in combination with
forskolin and dexamethasone and NT/N gene transcription was monitored by
RNase protection. PC12 celIs wcrc treated with NGF every thrce days and fresh
NGF was added 20 hr prior to treatmcnt with the indicated inducer
combinations. Consistent with the rcsults obtained after 12 hr of NGF pre-
treatment, the addition of a combination of lithium , forskolin, and
dexamcthasonc more effectively stimulated NT/N gene expression in PC12 cells
differentiated with NGF as comparcd to control cells (figure 4-2A). The level of
expression in celIs differentiated with NGF was as high as that observed in
100
Figure 4- NT/N genc induction in PC12 cells rollowing long- term treatment
with NGF. Either control PC12 cclls or cells lhat had bccn trcated with NGF (100
ng/ml) for 10 days werc induccd with eithcr NGF or lithium in combination
with dexamclhasone and rorskolin for the indicated times. The last addition of
NGF in long-tcrm NGF- treatcd cultures was 20 hr prior to induction. Nuclear
RNA (25 f.g) was analyzed using the RNase protection assay described in figure
6. A. Induction or inlron one-containing NT/N precursor RNAs (325 b
product) in eithcr control cells (opcn circles) or NGF-differcntiated cells (solid
circles) in response to trcatment wilh a combination or lithium , forskolin, and
dexamethasone ror the indicatcd limes. B. Same as in A except control cells
(open circles) or NGF- difTerenlialcd cells (closed circles) wcre treated with
NGF, forskolin , and dexamcthasonc.
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cells trcatcd with all four inducers simultaneously (see figurc 2- 6). These
results providc an indication that thc pathway identificd by lithium is present
neuronally-di fferen ti atcd PC12 cells.
The errects of long- tcrm NGF treatment on subscqucnt rcsponses to
either NGF , forskolin, and dexamethasone or just the latter two inducers were
examined to detcrmine whether NGF down-regulation persisted upon
prolonged exposure to NGF. In contrast to cclls pre-trcatcd with NGF for just 
, treatment with a combination of NGF, forskolin, and dexamethasone
stimulated NT/N gene expressIOn as C(Tcctively in long- term differentiated
cells as in naive cells (figure 4-2B), although with somcwhat delayed kinetics.
Treatment with forskolin and dcxamethasone following long-term exposure to
NGF also stimulated NT/N gene cxpression , although somewhat less effectively
than when fresh NGF was also addcd (dala not shown). Thesc results suggest
that eithcr the response to NGF, I"orskolin, and dexamethasone is only
transiently down-regulated or thal novel signalling components are induced
after long- term exposurc to NGF. The ability to induce NT/N gene expression in
differentiatcd PC12 cells suggesls that the pathways idcntified by both NGF and
lithium may be important for the regulalion of NT/N gcne cxpression in
neurons.
NGF and lithium in c mbination with dexamethasonc and forskolin do not
ivale rotein kinasc C in PC12 cclls. Lilhium has well-characterized effects
on the phosphatidylinosilol (PI) pathway (Berridge et al. 1989) which could
potentially account for ils ellecls 011 NT/N gene expression, sincc the AP- site
has been demonstraled lO mediatc al least some of the transcriptional effects of
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phorbol estcrs (Lam ph Cl al. 1988; Lec ct al. 1987). Extracellular stimuli can
alter the DNA binding or transcriptional activation of AP- factors through
activation of PKC (Binetruy ct al. 1991; Boyle ct al. 1991). Phorbol esters
strongly induce thc activity and rapid translocation of PKC from the cytoplasm
to the cellular membrancs. Howcver. PKC activity transiently declines to
undetectable levels upon conlinucd Slimulation with phorbol esters (Matthies
etal. 1987).
To examine whethcr induclion is associated with changcs in PKC
activity, an in vitro phosphorylation assay was used to quantitate PKC levels in
PC12 cell extracts. This assay is bascd upon the ability of PKC, in the presence
of phosphatidylscrine and calcium. to specifically phosphorylate histone HI
(Palfrey and Waseem 1985) and has bcen uscd prcviously to analyze PKC
activity in PC 12 cells (Damon Cl al. 1990; Matthics et al. 1987). In this
experiment, PC12 cclls wcrc lrcatcd for O. 1, 2 , 4, 6 or 8 hours with all four
inducers and fractionatcd into cylosolic and membrane cxtracts. These extracts
were incubatcd with y_ 32p- ATP and histone HI either in thc presence of
phosphatidylserine and calcium 10 lcsl for PKC spccific phosphorylation or
with EGTA as a non-specific conlrol. Thc samplcs were run on a 15%
SDS/polyacrylamide gel and exposcd 10 X-ray film (figure 4-3). Even though
the initial PKC activity was high , lhcrc was no funher incrcase in PKC activity
or in translocation to thc membrane fraction during the 8 hour induction
period. This rcsult dcmonstrates that treatment with a combination of these
inducers had no creecl on the compartmcntalization or activity of PKC during
'the intcrval examincd.
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Figure 4- PKC is not activated in fully induced PC12 cells. PC12 cells (-5 x 106
cells/time point) were treated with a combination of NGF, lithium,
dexamcthasone and forskolin. At the indicated time points (hours), cells were
harvested and fractionated into cytosolic (cytosol) and mcmbrane extracts. 5f.g
of protein were incubated with y_ 32 P-ATP (500 f.M) and histone HI (200 f.g/ml)
either in thc presence of phosphatidylserinc (50 f.g/ml) and CaCI2 (500 f.M) to
detect PKC specific phosphorylation (PS/Ca ' upper panel) or EGTA (500 f.M)
as a non-specific control (EGT A, lower pancl). The products were resolved on a
15% SDS/polyacrylamide gel and exposed to X-ray film: the autoradiogram 
own (12 hour exposure). The positions of the phosphorylated histones are
indicated by arrows
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Lithium activation does nOI uire rolein kinasc C. To determine whether
PKC is requircd for NT/N gcne aClivalion , PC12 cells wcrc prc-treated with 1
JlM phorbol 12-myristatc l3-acelate (PMA) for 24 hours in order to down-
regulate PKC prior to the addition of inducers. Figurc 4-4 shows an
autoradiogram in which thc levels of PKC werc measurcd in PMA treated cells,
using the above in vitro phosphorylation This experiment demonstratedass ay.
that exposure to I JlM PMA ror 24 hours resulted in the nearly complete loss
95%) of PKC activity rrom PC12 cells, consistent with previous reports
(Damon ct al. 1990: Matthics ct al. 1987). Furthermorc, PKC activity was not
restored by treatmcnt with any of thc inducer combinations tcstcd. To test
whether PKC was required ror NT/N genc activation, PC12 cells were treated
for 24 hours with 1 JlM PMA or lerl untreated prior to induction with NGF
and/or lithium, combination with dexamethasone and rorskolin. Detection
of the intron one-containing transcripts by RNasc protcction showed (figure
5), unexpectedly, that phorbol estcr prc-treatment potentiatcd NT 
transcriptional responses to all induccr combinations tested by approximately
fold, including responses involving lithium. These results demonstrate that
PKC is not required for NT/N gene activation by combinations of lithium, NGF,
forskolin, and dcxamethasone. In fact, thc pathways required for activation
may be constitutively suppressed through a PKC-depcndent mechanism.
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Figure 4- PKC activity is down-regulatcd in phorbol ester pre- treated PC12
cells. PC12 cells (-1 x 107 cells/condition) were either pre- treated with 
PMA (P) or left untreated (-) for 20 hours, and subseq uently induce-d with
either NGF and/or lithium in combination with dcxamethasone and forskolin
for the indicated times or len uninduced (NA). As a control , cells were also
treated with 100 nM PMA (P). Induction timcs (hours) are indicated. PKC
activity was assayed as In figure 3-5. Thc upper pancl represents specific
phosphorylation (PS/Ca++) while the bottom panel represents non-specific
phosphorylation (EGTA). Induction conditions are indicated above the
autoradiograph using the following inducer abbreviations: NGF, N; lithium, L;
forskolin, F: and dexamethasone, D. The inducers were used at the same
concentrations as described in Fig. 2-
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Figure 4- Down-regulation of PKC does not inhibit NT/N gene induction.
PCl2 cclls were either pre-treated with !l M PMA for 20 hours or not pre-
treated, subsequcntly trealed with the indicated inducer combinations, and
harvested at the indicaled limes. Nuclear RNA was prepared, and precursor and
spliced NT/N transcripts wcre quantitated using the RNAse protection assay
describcd in figure 2-6. The positions of the protected products resulting from
hybridization lO intron one-containing (325 b) and spliced transcripts (169 b),
as well as the 104 b protected product resulting from hybridization to sense
RNA standard, are indicated. Inducer abbrcviations and concentrations are as
described in figure 4-
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CHAPTER V
DISCUSSION
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This thesis addrcsses lhc problem of how extracellular signals regulate
NT/N gene expression in PCI2 cells and defines pathways which may be
important for controlling plastic changes within thc adult CNS. Several lines
of evidence indicatc thai cnvironmcntal factors, such as growth factors,
hormones and neurotransmitters play an cssential role in the establishment of
neuronal phcnotypcs during dcvelopment of the pcriphcral (Anderson 1989;
LeDouarin 1982) and ccntral nervous systcm (Renfranz ct al. 1991). Many
neuronal genes are induced within the adult CNS in rcsponse to both
physiol.ogical and pharmacological stimuli suggesling that extra-cellular
signalling also regulates CNS plasticily (Mcrchant ct aI. 1992; Naranjo et aI.
1991; Sonnenberg et al. 1989c). PC12 pheochromocytoma cells differentiate
neuronally in response to NGF and respond to scveral ncurotransmitters
providing a useful model to study neuronal diffcrentiation and plasticity
(Greene and Tischler 1982). Onc of the earliest transcriptional responses to
NGF in PC12 cells is the rapid induction of immediatc early gcnes (lEGs),
including scvcral that encode AP- lranscription factors (Morgan and Curran
1991). Ccrtain neuronal genes con lain consensus AP- sites within their
promoters, suggesting that the induction of AP- faclors may play a key role
in the establishment of ncuronal phenotypes both during development and in
the adult nervous syslem (Kislauskis and Dobncr 1990; Naranjo et aI. 1991;
Sonnenberg et aI. 1989c).
Several neuropeptidc genes thal contain AP- sequences are expressed
in the ncrvous system with kinetics that correlate with the expression of AP-
genes (Naranjo et al. 1991: Sonnenberg et al. 1989c) but because of technical
diffculties thesc transcription factors have not been shown to directly control
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neuronal genc transcription, in vivo. Since AP- factors and putative target
genes are similarly exprcsscd in PC12 cells, thesc cells are more amenable for
studying whether AP- l complexes mediatc thc rcsponse of extracellular
stimuli to neuronal gcnc transcription. The neuropcptidc. ncurotensin , and
NT/N mRNA are induccd in PC12 cclls by combinations of environmental
factors, including NGF, glucocorticoids , activators of adenylate cyclase and
lithium salts (Dobncr et al. 1988; Kislauskis and Dobner 1990). Previous
experiments have indicatcd that cis-rcgulatory elcments locatcd within the
NT/N promoter are nccessary for the synergistic action of these inducers, with
a consensus AP- sitc rcquired for the permissive affects of NGF and lithium
(Kislauskis and Dobner 1990). The NT/N promotcr is unique in that it appears
to be composed cntirely of inducible clements, which scrve to integrate
multiple environmental stimuli into a unified transcriptional response. The
expression of the NT/N gene 11 PCl2 cells thus providcs a model to analyze
mechanisms by which environmcntal stimuli alter neuropeptide gene
expression, including those mediated by AP- factors.
Experiments dcscribcd in Chaptcr 2 demonstrate that NT production in
PC12 cells is rcgulated principally at thc transcriptional levcl by combinations
of inductivc stimuli, although regulation of proNT/N protein processing may
also play a minor rolc. These rcsults arc consistent with transfection
experiments in which the 5' flanking rcgion of the NT/N gene conferred the
regulatory properties exhibited by the endogenous gcne to reporter genes
(Kislauskis and Dobner 1990). Howcver NT/N mRNA must be extremely stable,
since transient low Icvel activation of NT/N transcription produced high
levels of NT/N mRNA (Figurc 2- 5). In support of this conclusion NT/N mRNA
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can be detccted, by nucleasc protection without any reduction in steadyassays,
state levels for up to 96 hours after induction (unpublished observations). The
low level of expression of nuclear run-on transcripts made it necessary to
develop an alternative transcriptional assay to analyze NT/N gene expression.
Intron one-containing NT/N transcripts, detectcd in the nuclei of maximally
induced PC12 cells, accumulatcd with similar kinetics to nuclear run-on
transcripts, indicating that increascs in NT/N precursor RNA represent
changes in NT/N transcription. The dctection of prccursor RNA in the nucleus
has been prcviously uscd to assay changes in transcription when nuclear
run-on assays arc impractical (Fremcau et a!. 1989; Maurer 1981). The RNase
protection assay described in this thesis providcs a rapid, scnsitive assay for
the quantitation of NT/N precursor RN A in induced PC12 cells.
Analysis of NT/N prccursor RNA in cclls trcated with cither NGF or
lithium as the pcrmissivc induccr showcd that NT/N intron one-containing
transcripts arc induced with different kinetics in cach case. In cells treated
with NGF, dexamcthasone, and forskolin , a rapid and transient increase in
NT/N precursor RNA was observed, whercas a delayed response was seen when
lithium was used as the permissive inducer. The kinetics of NT/N gene
activation in cells treated with NGF, dexamethasone, and forskolin suggested
that the induction of AP- factors may regulate NT/N transcription, since NGF
rapidly induces AP- l gene and protein cxpression (Curran and Morgan 1986;
Sheng and Greenberg 1990). However, when PC12 cells were pre-treated with
either anisomycin or cycloheximide prior to thc induction with NGF,
dexamethasone, and forskolin , the rapid transient increasc in intron one-
containing transcripts was not attenuated. Thereforc, it is likely that post-
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translational modi l"cation and not de novo synthesis of AP- factors is
required for thc permissive effcct of NGF. Similar to the NT/N gene, cAMP-
induction of proenkephalin gene expression in C6 glioma cells, acting
through an AP- I-related element, is not inhibited by anisomycin (Kobierski et
al. 1991), in support of this conclusion. Thcrefore, post-translational
modification of constitutively cxpressed AP- factors may play an important
role in rapid transcriptional rcsponscs of the NT/N genc to NGF
dexamethasone, and forskolin.
It is unclear why the induction of AP- factors, such as c-Fos and c-Jun,
are not involved in thc activation of NT/N transcription in response to NGF,
dexamethasone, and forskolin. Thrcc possibilities could account for this. First,
nucleotide sequcnces would dictate which subset of AP- factors can interact
with the AP- site. Rcccnt obscrvations by G. McNeil have shown by gel shift
assays that certain AP- I complexes do not interact with the distal AP- site (G.
McNeil and P. Dobner unpublished results) supporting this possibility. Second,
an inhibitory AP- l factor, such as Jun-B, could be induced simultaneously thus
antagonizing the action of c- Fos/c-Jun complexcs (for discussion see below).
Third, post-translational modification could rcsult in the inactivation of
induced AP- factors. In support of this third possibility, c-Fos is extensively
modified in NGF-treated PC 12 cells (Curran and Morgan 1986), and the activity
of c-Jun has becn shown to be inhibitcd by phosphorylation at certain sites
(Boyle et aI. 1991).
Post-translat ional modifications of transcription factors, especially
phosphorylation, are an important link between signal transduction and
regulation of gene expression (Bohmann 1990). Figure 5- 1 diagrams a
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Figure 5- phosphorylation cascade activated by NGF and its influence on
AP- factors. NGF binding to the NGF receptor activates a tyrosine kinase
activity (1) which initiations thc sequcntial phosphorylation of mitogen
activation protcin (MAP) kinases (2). An unidentified MAP kinase kinase
kinase, (MAPKKK) which is, eithcr dircctly or indirectly, activated by NGF,
phosphorylates serine and threoninc rcsidues on MAP kinase kinase
(MAPKK). Active MAPKK subsequently activates MAP kinases (MAPK) by
phosphorylations at tyrosine and thrconine residues. MAPK induces the
activation of c-Jun (3) through the phosphorylation of serinc residues (63-73).
Src and Ras also influcnce the activity of c-Jun presumably by
phosphorylation of thc same residues (4). Ras seems to be a component of the
NGF pathway. The amino acid sequence similarity between the activation
domains of c-Jun, Jun- and Jun- suggest that these AP- factors may also be
regulated by this phosphorylation cascade or pathways involving Src and Ras.
MAPKKK
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potential phosphorylation cascade activated by NGF resulting in the trans-
activation of the AP- factor, c-Jun. I) NGF binds to cognate receptors (TRK),
thereby inducing protein tyrosine kinasc activity (Loeb ct al. 1991: Ross 1991).
2) NGF initiates a phosphorylation cascade involving the mitogen activated
protein (MAP) kinases (Boul ton et al. 199 \; Gomez and Cohen 1991). Activation
of MAP kinascs reqUIre both serine/threonine and tyrosine phosphorylations
and are the only known serine/thrconine protein kinases that are activated
by tyrosine phosphorylation (Gomez and Cohen 1991). 3) Phosphorylation by
MAP kinases positively regulates the activity of c-Jun by specifically
phosphorylating serine residues (63 and 73) within the activation domain of c-
Jun (Pulverer et al. 1991: Smeal ct al. 1991). 4) Simj larly, the proto-oncogene
products, Ha-Ras and V-SIT, also increase the transcriptional activity of c-Jun
through phosphorylations within the activation domain (Baichwal et al. 1991;
Binetruy et al. 1991). Both the ras and src oncogcnes induce neuronal
differentiation in PC12 cells (Alcma cL al. 1985: Bar-Sagi and Fcramisco 1985).
NGF- induced differentiation of PC 12 cells is inhibited by injcction of anti-ras
antibodies (Hagag ct al. 1986). Taken together, these results suggest that Ras
and Src may be components of a NGF signalling pathway, although their exact
placement within the phosphorylation cascade has not been determined
(Hagag et al. 1986; Szeberenyi et al. 1990). Jun- and Jun- have similar
phosphorylation sites to that of c-J un (Figure 5- 1), thus other AP- factors
could be activ ted post-translationally by MAP kinases or the signallng
cascade initiated by the ras- like G-proteins or src-tyrosine kinase activity.
Jun-D is constitutively expresscd in PC12 cells and is not regulated by any of
the factors which act ivate NT/N transcription (Figure 3-7 and dc Groot et al.
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1991; Rydcr ct aI. 1989). Intcrcstingly, Jun-D may be involved in the transient
activation of proenkephalin through an clement thatgcnc expression
resembles both an AP- 1 site and a CRE (Kobicrski et al. 1991). Transactivation
by Jun- in F9 cells requires co-exprcssion of the catalytic subunit of PKA,
although it is unclear whcther Jun- is phosphorylatcd by PKA (Kobierski et
aI. 1991). NGF could influence NT/N gcne transcription through the post-
translational modification of c- Jun , Jun- or perhaps othcr constitutively
expressed AP- factors.
Following thc initial pcriod of NT/N gene activation in cells treated with
NGF, forskolin, and dexamethasonc, transcription was rapidly extinguished by
mechanism that required newly synthcsized proteins. Anisomycin treatment
prolonged the exprcssion of intron one-containing transcripts and this effect
was not due to either a gcncral inhibition of splicing or anisomycin effects on
signal transduction (Mahadevan and Edwards 1991). These rcsults suggest that
NGF induces a transcriptional inhibitor which rapidly attenuates NT/N gene
expression. One possibility would be that NGF is inducing an AP- factor, such
as Jun-B, that acts as a ncgativc regulator of transcription. The kinetics of
expression of jun- activation correlate well with the attenuation of NT/N
gene expression (Figurc 3-7 and Bartel et al. 1989). June has been shown to
repress c-Jun activation of singlc AP- sites in co- transfected F9 embryonal
carcinoma cells (Chiu et al. 1989), and to inhibit the transforming and trans-
activating activities of c-JlIn in prtmary rat embryonic cells (Schutte et aI.
1989). Co-transfection experimcnts have demonstrated that Jun- is a potent
inhibitor of the PKA-dependcnt activation of proenkcphalin transcription by
Jun-D, suggesting that JlIn- rcsponsible for extinguishing transcription
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after the initial forskolin induction (Kobicrski et al. 1991). The results
reported in Chapter 3 arc consistent with the notion that the rapid
inactivation of NT/N transcription, following induction by NGF
dexamethasonc and forskolin, may involve thc de novo synthesis of an
inhibitory AP- factor.
In contrast to the rcsponsc to NGF, forskolin, and dexamethasone,
responscs involving lithium were markcdly attcnuated by anisomycin pre-
treatment indicating that lithium action requires newly synthesized proteins.
The importance of thc AP- site for responscs to inducer combinations
involving lithium provides an indication that increased synthesis of AP-
proteins is required for the rcsponsc (Kislauskis and Dobner 1990). RNA blot
analysis was uscd to examinc thc cffccts of lithium on the expression of the
seven charactcrizcd AP- PC 12 cells. Li th i um acted synergisticallygenes in
with dexamethasonc and !"orskolin to increase c-fos and jun- gene expression
and activated c-jun ,fra- and c-fos gene expression with delayed kinetics (
hours), consistent with a role for the corresponding AP- proteins in NT/N
gene activation. These rcsults indicatc that components of the lithium specific
signalling pathway are interacting with the regulatory regions of these AP-
genes. Analysis of the promoter regions of c-fos, c-jun, and fra- may be
useful in identifying cis-rcgulatory clements required for activation and aid
defin ing thc signalling pathway identificd lithium. The delayed kinetics
these responses may circumvent thc potential ncgati ve effects Jun-
since the jun- gene transicntly induced pnor thc dclaycd activation
the c-jun and fra- gcnes in clls treated with lithium, dexamethasone and
forskolin. In maximally stimulatcd cells, lithium could also override the
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inhibition induced by NGF, slncc lithium prc- treatmcnt potcntiates transient
activation of cclls trcatcd with NGF, dcxamethasonc and forskolin (figure 4- 1).
These results suggest that lithium-regulation of c-Jun/Fra- 1 or other AP-
heterodimcr levcls may underlie its transcriptional effccts on both the NT/N
gene and a CAT fusion gene controlled by multimerizcd AP- sites. However,
the relatively modest effects or lithium on AP- 1 gene exprcssion leave open
the possibility that the induction of nove! AP- proteins or factors that modify
AP- activity is involved in thc response.
Lithium has been shown to innuence signalling through the PI
pathway (Berridge et al. 1989) and may have a morc general effcct on G
protein- linked receptor signalling (Avissar et al. 1988). Lithium influences PI
signalling by inhibiting mono- and polyphosphatases requircd for the
regeneration of phosphatidylinositol in the absence of exogenous inositol
(Berridge ct al. 1989). The inhi bi tion of thesc phosphatases causes the
accumulation of mostly inactive phosphorylated forms of inositol , however, 
GH3 cells therc is an increase in lcvels of diacylglycerol (DAG) which is
required for PKC activation (Drummond and Racburn 1984). Lithium has been
shown to potentiate cholincrgic agonist activation of c- fos gcnc cxpression in
PC12 cells (Kalasapudi et al. 1990) and TIS genc expression in cultured rat
astrocytes (Arenander et al. 1989) and these effects may be mediated -through
PKC. However, expcrimcnts in chapter 4 demonstratcd that the PKC pathway is
not required for NT/N genc activation in PC12 cclls. Interestingly, PKC . down-
regulation enhanced NT/N gcne transcription , for all induction conditions
tested, suggesting that PKC signalling may be important for tonically
suppressing NT/N transcription. The constitutive activation of PKC in naive
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and fully induced PC12 cells sUPPOrLs this conclusion (Figure 4-3). Coupled
with previous observations indicating that Ca
++ 
has only a modcst effect on
NT/N gene cxpression (Tisch ler et a!. 1991), thesc resul ts suggest that lithium
well-charactcrized effects on PI signalling are not responsiblc for its effects
on NT/N gcne transcription. LiLhium also transcriptionally activates a CAT
fusion gene construct controllcd by multimerized AP- sites in PC12 cells and
this rcsponse is essentially unalLered in protein kinase A-deficient PC12 cells
(Dobncr _ et a!. 1992). These resulls taken togethcr strongly indicate that
lithium eithcr affects signalling componenLs downstream of these kinases or
that lithium affects a novel signalling pathway. Thercfore, PKC is not required
for the permissive rcsponse to lithiull but may bc necessary for maintaining
low level NT/N gcne exprcssion in unstimulated PC12 cclls.
Thc signal transduction pathways which modulate NT/N gene
transcription in PC12 cells may be important in maintaining NT/N gene
exprcssion within Lhc CNS. NT/N mRNA-conLaining cells are discretely
localized within the rat brain , predominantly within the limbic regions
(Alexander et al. 1989b). Studies cxploiting immunostaining or in situ
hybridization of unstimulatcd brain scctions have shown a significant
anatomical specificity or c-fos and other lEGs (Sagar ct a!. 1988; Sonnenberg 
al. 1989a). Thercfore, the constitutive activation of signalling pathways
utilzing AP- factors may be irnportanl for maintaining neuronal gene
expression. This concept is clearly demonstrated in the rat visual cortex by the
expression of the immediaLc early gene, zif268 (Worlcy et a!. 1991). Constitutive
levels of zif268 are maintained through visually induced synaptic activity.
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Thesc results suggcst that IECI factors play rolc in maintainingtranscri pI ion
normal brain physiology.
Many physiological and pharmacological induccd cvents in the CNS
correlate with the transicnl cxpression of AP- l gencs and proteins suggesting
that AP- factors are important regulators of plastic changcs within the CNS
(Doucet et al. 1990: Morgan ct al. 1987; Sonnenbcrg ct al. 1989a). In one study,
messcnger RNAs encoding lhc AP- factors c- fos , c- jun, and junB were
rapidly and transiently induced in rat hippocampus following chemically
induced scizures (Sonnenberg et al. 1989c). Subsequcnt to the appearance of
these transcripts, a transienl burst of procnkephalin gcnc expressIOn
occurred in thc the same neurons, suggesting that the induction of AP-
regulates procnkephalin gene expression in the hippocampus. The
requiremcnt of an AP- Iike clcment within thc proenkephalinregul atory
promoter supports this conclusion (Kobierski et al. 1991). In a follow-up
experiment, agonists of the glutamate rcceptor, a major neurotransmitter
receptor within thc brain , increased c-fos and fra- gcne expression and AP-
DNA binding activity in thc mousc hippocampus (Sonnenberg et al. 1989b),
further supporting a role for AP- factors in mediating transcriptional
responses to physiological stimuli. In another casc, prodynorphin mRNA is
expressed within the dorsal horn of the rat CNS after noxious stimulation with
kinetics that are consistcnt with the expression of AP- target genes (Naranjo
et al. 1991). The prodynorphin genc also contains a functional AP- site within
its promoter (Naranjo el al. 1991). Taken togethcr, thcse expcriments suggest
that lEGs, including thosc encoding AP- proteins, function as mediators 
long-term t ransc ri p tj 0 na to cnvironmcntal factors in neurons.responscs
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Recent expcriments have indicated that regulation of NT/N gene
expression in the rat brain requires the convergence of multiple signallng
pathways, including those acting through AP- proteins. The use of an intron-
specific probe for in situ hybridii', ation has shown rapid and transient
increase in NT/N transcription (peaking between 3 to 7 hours) within the
dorsolateral striatum of rats, al'er treatment with a single dose of the
dopamine antagonist, haloperidol (Merchant et al. 1992). Haloperidol also
transiently activates c- fos gcne expressIOn and incrcases c-Fos
immunoreactivity in the striatum and nucleus accumbens (Miller 1990;
, Robertson and Fibigcr 1992). Haloperidol is also likcly to increase cAMP levels
in responsive neurons by blocking dopamine 02 receptors which are
negatively linked to adenylatc cyclase (Onali et al. 1985). Consistent with our
results in PC12 cells, haloperidol induction of the NT/N gene within the rat
striatum and nucleus most likely depends upon convergentaccumbans
signalling pathways, the phosphorylation of CRE- bindingpresumably
proteins by the adenyl ate cyclase/protein kinase A pathway cooperatively
interacting with the transicnt induction of AP- factors. Differcnt signals
appear to be essential for NT/N genc cxpression in other discrete brain
regions, particularly in thc hypothalamus (Alexander et al. 1989b). Expression
in the medial preoptic female rats is strikingly dependent onarea In
circulating estrogen (Alexander et al. 1989a) and varies throughout the
estrous cycle implying that NT may be an important rcgulator of the pre-
ovalutary surge in rats (Alexandcr ct al. 1991). Similarly, colchicine and
reserpine specifically induce NT/N gcnc expression in the paraventricular
hypothalamus (Ceccatelli el al. 1991 a). These responses may be stress-related,
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perhaps indicating that corticos!croids rcgulatc NT/N gcne expression in the
CNS (Ceccatelli et aI. 1991 a). In support of this conclusion , glucocorticoid
receptor immunoreactivity is co- localized to NT containing cells within the rat
brain (Cintra et aI. 1991). Takcn togcthcr, thcse rcsults clearly indicate that
different environmcntal stimuli play key region-specific roles in regulating
NT/N gene expression in the CNS.
NGF and lithium stimulate distinct intracellular pathways that are
required for NT/N gcne expression in PC12 cells and that could be important
for controlling the expression of thc genc In the nervous system. NGF is a
member of a family of structurally related neurotrophic factors that have
recently bcen shown to cxert Iheir effects through related high affinity
receptors encoded by the trk oncogcne family (Loeb et aI. 1991; Ross 1991). NGF
and other members of this family are expressed in distinct pattcrns in the CNS
(Ceccatelli ct aI. 1991b; Isackson e! aI. 1991) and could play a rolc in regulating
neuronal gene expression, including the NT/N genc. Interestingly, NGF is
synthesized in hippocampus (Ayer- LcLiever ct aI. 1988) and NGF mRNA is
induced by limbic seizures within the same ncurons (Gall and Isackson 1989).
Like NGF, the pathways identificd by lithium may also be important in the CNS.
The demonstration that lithium can cooperatively activatc NT/N gene
expression aftcr long- term NGF trcatment of PC12 cclls indicatcs that the
pathway identified by lithium is aClive in neuronally-differentiated cells. The
activation of this pathway by physiological ligands could thus play role in
the generation of the complex paLtcrn of NT/N genc cxprcssion observed in
the rat CNS. Results prcsented in this thesis suggest that one action of lithium
within the brain could be 10 enhancc thc expression of AP- l genes. This
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pathway could then cooperate with other signalling pathways to alter
transcriptional responses in neuronal cells elicited by growth factors,
neurotransmittcrs or depolarization. Activation of c- fos cxpression by
muscarinic agonists acting through the PKC signalling pathway in rat brains
is enhanced by trcatmcnt with lithium (Weiner, 1991). Identification of the
endogenous I igands that acti vate this pathway thus becomes paramount in
understanding thc cffect or lithium on the physiology and long- term plastic
changes within thc CNS.
NT/N mRNA is localized to the same regIOns of the rat brain as NT- like
immunoreactivity, with the exccption of the CA region or the hippocampus
and the subiculum (Alcxander et al. 1989b). NT-like immunorcactivity has not
been observed in thes regions within the adult rat, evcn though abundant
levels of authcntic NT/N mRNA wcrc detccted by in situ hybridization
(Alexander et al. 1989b). Similar discrcpancies betwcen mRNA abundance and
immunostaining have been obscrvcd with othcr neuropeptides (Schiffmann
and Vanderhacghen 1991; Segerson ct aI. 1987). Four likely possibilities could
explain this discrepancy: 1) the proNT/N peptidc is alternatively processed
into peptides othcr than NT, 2) the NT peptidc is turned over rapidly, 3) the
proNT/N protein is rapidly degraded after translation and 4) NT/N mRNA is not
translated or is poorly translated. To dctermine if altcrnative processing of
proNT/N could account ror this discrepancy, an experiment was done to detect
proNT/N pcptides in these regions by immuno-histochemistry, using the Rb 3
antiserum. Surprisingly, proNT/N was not detectcd in cithcr the subiculum or
the CAI region of thc hippocampus (M, Alexandcr, B. Bullock and P. Dobner,
unpublished results). However, proNT/N was dctected in other areas that
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contain both NT and NT/N mRNA, such as the arcuatc nuclcus, lateral septum,
and paraventricular nucleus. Even though further experimcnts need to 
done to improve the sensitivity of thcsc signals, these results suggest that
NT/N mRNA may be regulated al tile level of translation within the cells of the
rat hippocampus and subiculum, thus providing for a novcl mechanism 
regulate ncuropcptide gene expression in the CNS.
The region specific localization of diffcrent processed forms of
precursor neuropcptides within the CNS has bccn well documcnted (Eiden
1987: Krause et al. 1990; Mains et al. 1983), although the elucidation of
mechanisms by which differential has been limited.processllg occurs
Differential forms of processed proNT/N peptides have been observed within
various tissues in several mammalian species, including the rat (Carraway 
al. 1991; Shaw et al. 1990a). Experiments dcscribed in chapter 2 showed that
lithium inhibits thc formation of mature NT in PC12 cells (Table 2- 1). Lithium
could altcr proNT/N processing by two possible mechanisms. 1 )NT/N mRNA in
lithium induced cells could be expressed at such high levels that the
processing machincry is saturated and only a limited amount of peptide is
being processed. 2) lithium is specifically inhibiting protcolytic enzymes
needed to process proNT/N into maturc peptide. Further studics will be needed
to determine whether lithium may speci rically rcgulatc the proteolytic
processing of mature NT peptide.
Thc observation that most proNT/N peptide is partially processed or
unprocessed (:: 80%) in PCI2 cclls suggcsts that an important mechanism for
regulating NT synthcsis may be through post-translational attenuation, a
phenomcna by which precursor peptidc is inhibited from being fully
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processed and accumulates in unprocessed non-bioactive forms (Rehfeld
1990). The mcchanisms by which neuropeplide biosynthesis can be regulated
in this manner are not wcll dclincd. Many post-translational processing
events could be responsible for thc inhibition of proteolytic cleavage,
including phosphorylation. sui fonation C-terminalglycosylation. and
amidation (Mains et al. 1983). Of panicular interest is the inhibition of
progastrin p roccssi ng gastrinoma ex tracts,by phosphorylation. In human
unprocessed progastrin was less likely to be phosphorylatcd when compared to
the corrcsponding fully processcd pcplide. suggesting that phosphorylated
progastrin might be morc readily clcaved (Varro et at. 1990). Progastrin is
phosphorylated at a serine residue within a consensus casem kinase site
which overlaps the C-lcrminal protcolytic cleavage site (Dockray et al. 1987).
Similarly, the proNT/N protein contains a consensus protein kinase A
phosphorylation site (N- leu- lys-arg-ala-ser- tyr-C), which is located within its
C-terminal cleavagc site. Therefore. phosphorylation induced by forskolin
could altcr the ability of proNT/N peplide to bc proccssed. Expcriments where
high levels of precursor NT/N protcins are induccd in either the presence or
absence of forskolin will aid in undcrstanding thc role of the C-terminal
phosphorylation attcnuation.and post - t ra n sIaL i on al
In summary, the expcrimcnts in this thesis show that the permissive
agents NGF and lithium when combined with dcxamcthasonc and forskolin
induce NT/N transcription in PCl2 cclls through two distinct signalling
pathways. Post- translational of constitutively expressed AP-mod i fi c al ion
factors may be rcquired for thc aCLivation by NGF, dexamethasone, and
forskolin, whereas, newly synlhcsi/,cd AP- proteins may subsequently down-
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regulate NT/N gene expressIOn. In contrast, lithium activatcs a permissive
pathway which may rcsult in the dc novo synthesis of AP- l complexes.
Lithium influcnce on NT/N gcne expression does not require protein kinase
and thus is probably nOI acting through thc phosphatidylinositol signal
transd uction pathway. NGF and are active in neuronally-differentiatedlithium
PC12 cells suggesting that these agents de/'ne signal transduction pathways
that are important for regulating the NT/N gene in neurons.
130
Ma terials and Methods
terial Most restriction and othcr enzymes wcre purchascd from
Boehringer Mannheim Biochemicals; Stu I was from New England Biolabs; 32p-
nucleotides, 3 H-Ieucine and 35 S-methionine wcre from Amcrsham Corp.
unlabeled nucleotidcs were from Pharmacia: anisomycin, cycloheximide,
forskolin, nuclease P1, indolcacrylic acid, Thiamine B 1, lysozyme, histone HI,
phorbol 12-myristate 13-acclate (PMA) and formalin fixcd Staphylococcal
aureus (Staph A) were all from Sigma: nerve growth factor (2.5 S) was from
Bioproducts for Scicnce Inc. (Indianapolis, IN): dexamethasone was a gift from
Merck, Sharp and Dohme (West Point, PA); and lithium chloride, formamide,
guanidiniul' thiocynatc and formaldehyde wcre from Fluka. In vitro
packaging extract (Gigapack) was obtained from Vector Cloning Systems (San
Diego, CA). Freund's complete and incomplcte adjuvant were purchased from
DIFCO Laboratorics: Rnasc- frce DNase I was from Worthington Biochemical
Corporation (Freehold, NJ); and Zctabind nylon membranes from CUNO
Laboratory Products (Meridan, CT). Recombinant plasmids for mouse c-jun,
jun- B, and jun- were obtained from the American Type Culture Collection.
Additional AP- 1 cDNA clones werc generously provided by Drs. J. Bellasco and
M. E. Grecnbcrg (mouse c-fos), R. Bravo (mouse fos B), and M. Matsui (human
fra 1, fra 2).
ell Culturc PC12 cells wcre maintained in Dulbecco s modified Eagle s medium
(DMEM , GIBCO) supplemcntcd with 10% hcat- inactivated horse serum (GIBCO),
5% fetal bovinc serum (Sigma), and antibiotics CGIBCO) as described (Greene
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and Tischlcr 1976). Induccrs wcrc addcd to thc culture medium from
concentrated slocks lO f'nal concentrations of 1 j.M dexamethasone, 1 j.M
forskolin, 100 ng/ml nerve growth factor, and 20 mM lithium chloride. To
inhibit protcin synthcsis, cells wcre prc-trcated for 30 minutes (unless
indicated otherwise) with either 50 j.M anisomycin or 10 j.g/ml cycloheximide
(Greenberg ct a\. 1986). For protcin kinase C (PKC) down-regulation
experiments, PC12 cclls wcre trcatcd with PMA (1 j.M) for 12 hours prior to
induction as described (Damon ct al. 1990: Matthies el a\. 1987). PC12 cells were
plated on collagcn-coaled tissuc culture dishcs for ncuronal differentiation in
response to long- tcrm NGF trcatmenL (Greene and Tischler 1976).
ola n of lhc Rat NT Gene. gcnomic library was constructed to isolate
the rat gene (Kislauskis et al. 1988). High molccular weighl DNA, greater than
20 kb in size, was extracted from rat testes as dcscribed (Bell et al. 1981). The
DNA was partially digested with the restriction cnzyme Sau 3A (0.004 units/Ilg
DNA) for 1 hour at 37 oC and fractionated on a sucrose gradient (10-40%).
Aliquots, corresponding to a sizc range of 10 La 20 kb, were pooled and ethanol
precipitated. Size-sclecled DNA was ligated into EMBL 4 phagc arms (Dente et ai.
1985), digested with Bam HI , at a ratio of 2:1 (insert:arms), packagcd into phage
particles (Gigapack) and infccted into E, Coli K802 bacterial cells as described
(Sam brook ct ai. 1989). The lilcr of thc library was dctermined to be
approximately 5.5 X 106 pfu/ml of lysate. Approximately 3.6 X 105 independent
recombinants wcrc platcd and scrcencd using standard protocols (Sambrook 
ai. 1989). Thc library was probcd with 32P-radiolabelcd NT-8A, a canine NT/N
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cONA clone (Oobner et a!. 1987), which was labeled by nick translation (Rigby
et al. 1977) aftcr linearization with Eco RI. Hybridization was performed in
1 X NaCI/sodium citrate solution (I NaCl/sodilim citrate = 0. 15 M NaCl, 0.015 M
sodium citrate, pH 7.0), 10 X Dcnhardt s solution (1 X Dcnhardt s solution =
bovine serum albumin, polyvinylpyrrolidine, and ficoll all at 0. mg/ml), 50
mM sodium phosphatc buffcr (pH 7. 0), 0.5% sodium dodecyl sulfate (SDS) at
60 oC. Filters were washed in sevcral changes of 2 NaCI/sodium citrate, 0. 1 %
SDS at room tempcraturc followcd by a wash in the same solution at 50 o
Three positivc clones, rNTI8, rNT 19, and rNT23 wcre identified and plaque
purified. rNT18 containcd the full length rat NT/N gcne and was used for
further analysis (Kislallskis el a!. 1988).
smid All plasm ids werc propagatcd in the E. coli bacterialCons ructions.
strain, HS 101, and purified by standard protocols (Sam brook et a!. 1989). For
riboprobc synthesis. the following DNA fragments were subcloned into pGEM4
vector DNA (Promega). pGEM- E II- NT was produccd by ligating a 489 nt Ora 
Eco RI fragment of rNT18 (Kislauskis et a!. 1988), containing 5' flanking
sequences, exon 1 and part of intron 1 of thc rat NT/N gene, into Sma I- Eco 
digested pGEM 4. pGEM-rNT4 was produced by ligating a 336 nt Sgl II-Eco RV
fragment of rNTl8 (Kislauskis et al. 1988), containing exon 4 of the rat NT/N
gene, into Sma I- Sam HI digcsted pGEM 4. A 562 nt Eco RI fragment derived
from a subcione of the A T14 human o:- tubulin gene (Lemischka and Sharp
1982) was ligated into Eco RI digcsted pGEM4 to gcnerate a probe spanning part
of intron 3 (165 nt) and exon 4 (383 nt) of the rat o:- tubulin genc. A 944 nt Eco
RI-Pvu II fragment of the human fra- F89 clonc (Matsui et al. 1990) and a
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1008 nt Eco RI fragment or thc human fra- F29 clonc (Matsui et a\. 1990) were
subcloned into Eco RI-Sma I and Eeo RI digestcd pGEM 4 , rcspectively.
For the production of preproNT/N fusion proteins, thc appropriate
sequences of a NT/N cDNA clonc (rbNT (Alexander et al. 1989b) were
subcioned, in- frame, into the pATH 2 bacterial expression vector (Kleid et a!.
1981). pATH-rbNT was constructed by ligating the 1130 nt Pvu II - Bam HI
fragment of the rat NT/N cDNA clonc (rbNT), containing nearly the entire
coding region (lacking the rirsl 7 amino acids) along with 200 nucleotides of 3'
untranslated rcgion, into thc Sma I and Eco Rl sitcs of pATH 2. To obtain RNA
coding for the full length prcproNT/N, the 1120 nt Pvu II-Eco RI fragment of
rbNT was ligated to thc Hind III - Pvu II fragment of the canine NT/N cDNA
and subcloned into the Hind III - Eco RI sitc or pGEM4 to produce pGEM-crhNT.
Pro of antiserum to roNT Fusion protein production and
purification was as dcscribed (Klcid Cl a\. 1981). Briel1y, HBIOI cells,
transformed with pATH-rbNT, werc grown at 37 o overnight in M9 CA media
(6 g Na2HP04, 3 g KH2P04, 0.5 g NaCl , 1 g NH4CI, 5 g casamino acids, 0.25 g
MgS04, 15 mg CaCI2, 2 g glucose, and 10 mg Thiamine B 1 per liter of dH20, pH
5) containing ampicillin (0. 1 mg/ml) and I-tryptophan (10 J.g/ml in 0. 1 M
KOH). A 1 :100 dilution was grown in 100 ml M9 CA (lacking I-tryptophan) to
mid-log, induced with indolcacrylic acid (10 Ilg/ml in absolute ethanol) and
grown for an additional 6 hours at 37 oC with vigorous shaking. The cells were
left overnight at 4 oc. Bacterial cells werc pelletcd (1 000 X g, 10 minutes),
resuspended in 20 ml lysis burfcr (50 mM Tris- HCI, 5 mM EDTA .3 mg/ml
lysozyme, pH 7.4) and incubatcd 011 ice for 2 hours. An additional 30 minute
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incubation was done after adding 1.4 ml or 5 NaCI and 1,5 ml of 10% NP-40.
This solution was sonicated lo rcduce viscosity and ccntrifuged at 8,000 X g for
20 minutes. The pellct was washed twice wilh 20 ml 1 M NaCl , 10 mM Tris- HCI,
pH 7.4, once with 10 mM Tris- HCI , pH 7.4, resuspended in 150 /.1 2x SDS/gel
loading buffer (1 x SDS/gcl loading buffer = 10% glycerol , 5% 
mercaptoethanol ( ME), 3% SDS, 62. 5 mM Tris-HCI, 0.01 % bromphenol blue, pH
8) and loaded on a 10% SDS/polyacrylamide gel (Laemmli 1970). The fusion
protein was visualized by a modi fied procedure of Nelles and Bamburg (Nelles
and Bamburg 1976). Briel'y, the gel was washed 3 X 11 Ice cold dH20, soaked in
ice cold 0.25 M KCl, 5 mM I)-ME for 5 minutes, and rinsed in ice cold 5 mM 
until precipiLated bands were detected. Thc appropriaLc band was excised from
the gel and used direclly for immunizations.
Immunizations wcre performed using standard proccdures (Harlow and
Lane 1988). A gel slice containing approximately 300 /.g of TrpE-NT/N was
homogcnized with Freund's complete adjuvant and equal amounts were
injected subcutaneously into the backs of two New Zealand white rabbits. Two
weeks later each rabbit was boos led wilh approximately 50 /.g of TrpE-NT/N in
Freund' s incompletc adjuvant. Starling twelve days latcr blood was collected at
three day intervals, and the scrum was proccssed and titcred. When the serum
was determined LO contain a high liter of antibodics to TrpE-NT/N, remaining
blood was collected, the serum was storcd at -20 oC and thc rabbits were
sacrificed. The IgG fraclion was affinity purified on protein A beads using
established procedures (Harlow and Lane 1988).
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Imm uno reci i t at ion. For titcring thc antiserum raised against TrpE-NT/N, an
immunoprecipitation assay was developed. Sense-strand crhNT RNA was
transcribed from pGEM-crhNT with T7 RNA polymerase following linearization
with Nhe I. crhNT RNA was translated in rabbit reticulocyte lysate (Promega)
containing 35S- thionine (800 Ci/mMole) as described (Titus 1991). 1 III of
lysate was mixed with 200 III PBS-SDS (1 X PBS, 0. 1 % SDS: 1 X PBS = 8 g NaCl, 0.2 g
KCI, 1.44 g Na2HP04, 0.24 g KH2P04 ) along with various amounts of either pre-
spun antiserum (10,000 X g, 10 minutes) or isolated IgG fraction and incubated
on ice for hour. The antibody-antigcn complex was isolated by affnity
absorption on formalin fixcd Staph as described (Kessler 1975). The
antiserum-translation mix was incubated with 20 III of washed Staph A on ice
for 30 minutes. This mixture was layered on top of a sucrose cushion (1 M
sucrose, 3.65 X PBS, 0.5% NP-40, I % deoxycholate, 1 mM EDT A, 0. 1 % SDS, 5 mM
methionine) and spun at 10,000 X g, for 10 minutes. The pellet was washed 2 X
with PBS-SDS and resuspendcd in 1 X SDS/gel loading buffer. The
immunoprecipitated products wcrc resolvcd by 15% SDS/PAGE (Laemmli 1970)
and subjected to standard rIuorographic techniques (Hames and Rickwood
1981). Staph A was washed and resuspcnded (10% w/v) in PBS-NDBS (1 X PBS,
5% NP-40, 1 % deoxycholatc, 0. c/o SDS, mg/ml bovinc serum albumin (BSA),
5 mM methionine).
ProNT/N was immunoprccipitHted and analyzed from mctabolically
labeled PC12 cells (sec below) by essentially the same method, except that cell
extracts (equal counts brought up to 200 III with PBS-SDS) were incubated with
the appropriate amount 0(' antiserum or IgG fraction. The wash and cushion
buffers also contained 5 mM leucine with or in place of methionine.
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To make radiolabelcd molecular wcight markers, pGEM-crhNT was
linearized with thc following rcslriction enzymcs; Nhe I, Eco RV, Hha I, BgI II,
and Ode l. Aftcr transcription with T7 RNA polymcrase, these RNAs were
translatcd in rabbit rCliculocytc Iysatc and immunoprecipitated as described
above to producc 35S-labeled peplidcs of thc following predicted molecular
weights, 19670 (full length), 14030, 7542 , 3850, and 2548 daltons, respectively.
In vivo met oli labelin of PCI2 cclls. For continuous labeling, PC12 cells
1 X 106 ) were pclletcd (500 X g) at 37 oC and washcd once with 5 ml of OMEM
lacking either leucine or mcthionine (Sigma) and dialyzed sera (10% horse
and 5% fetal bovinc), rcsuspendcd in 0. 8 m( of the samc media and placed in a 6
well culture platc. Sera was dialY/.ed in 1 X Earle s balanced saline (1 X EBS =
65 g CaCI2, 2 g MgS04, 4 g KCl, 68 g NaC!. 1.4 g NaH2P04 and 10 g glucose per
liter dH20). These cells wcrc incubatcd for 15 minutcs in a C02 incubator at
37 oc. An additional 200 III of the mcdium described abovc, containing 3H-
leucine or 35 S-mcthionine was added to thc cells and the cells incubated for
various times. At the end of the labcling time, cells wcre transferred to a 1.5 ml
centrifuge tubc, wash cd with icc cold 1 X PBS and placed on ice. The cells were
pelletcd (500 X g) at 4 oC for 5 minulcs, rcsuspcnded in NP-40/00C lysis buffer
(l % NP-40, 0.5% deoxycholatc in I X PBS) and incubatcd on ice for 30 minutes.
The extracts wcre clarified by two successive centrifugations, 1500 X g followed
by 10,000 X g. both for 5 minutcs at 4 oc. Labeling efficiency was determined
by TCA precipitation (scc bclow) and equal counts wcre immunoprecipitated.
Pulse-chase cxperiments wcrc donc cssentially the same except that after a 
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minutes labeling period, cclls wcrc washcd and incubated in serum-
supplemcntcd DMEM containing lO unlabeled mcthionine (10 mM).
Nuclear run-on transcri tion assa Nuclci werc isolatcd essentially as
described (Ausubcl ct al. 1989; Grcenbcrg ct al. 1985). PC12 cells (approximately
5 X 107/time point) wcrc harvested and washed twice with ice cold 1 X PBS. Cells
were lysed in 4 ml NP-40 lysis buffer (0.5% Nonidel P40, 10 mM NaCI, 10 mM
Tris-HCI, 1.5 mM MgCI2, pH 7.4) by gcnLly vOr!cxing (Penman 1969). Nuclei
were pelleted by centrifugation (500 X 
g) 
for 5 minutes and thc supernatant
was transfcrrcd to a separate lube (cytoplasmic fraction). The nuclear pellet
was washed in 4 ml NP-40 lysis buller and repelletcd as above. Nuclei were
resuspended in 180 IJI ice cold 2 transcription buffer and immediately labeled
(1 X transcription buffer = 35% glycerol, 10 mM Tris-HCl, 5 mM MgCl2, 80 mM
KCI , 0.2 mM EDTA , pH 7.5) (Cclano el a!. 1989)
In vitro labeling of nascent NT/N transcripts was performed as
described (Celano et al. 1989). Esscntially, nuclei in 1 X transcription buffer
containing 0. 5 mM dithiothrcilol (DTT), 4 mM cach of ATP, GTP, CTP and 20 IJI
(200 IJCi) of (X- 32p- UTP (3000 Ci/mmol) were incubatcd at 30 oC for 15 minutes
with vigorous shaking. To this mixture, 10 IJI of RNasc- free DNase (10 mg/ml)
and 10 IJI of CaCl2 (20 mM) wcrc added and the mixture incubated at 30 oC for 
additional 5 minutes. The reaction was cnded by adding 2 IJI of proteinase K (10
mg/ml), 25 IJI 10 X SET (1 X SET = 0.5% SDS, 5 mM EDTA, 10 mM Tris-HCI, pH 7.
and 5 1J1 yeast RNA followed by incubation at 37 oC for 30 minutes. RNA was
isolated by solubilizing nuclei in 550 IJI guanidinium solution (4 M
guanidinium thiocynate, 25 11M sodium citratc, 0.5% sodium sarcosyl , 100 
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ME, pH 7. ()), 90 I sodium acetate (pH 5, 0), 900 l phenol , and 180 
chloroform on ice for 15 minutes. Aftcr centrifugation (10,000 X g) for 5
minutes, the aqucous phase was transfcrred to a microfuge tubc and RNA was
precipitated with 1 volume of isopropanol at -70 oC for 30 minutes. The RNA
was rccovered by centrifugation (10,000 X 
g) 
for 15 minutes, resuspended in
360 I guanidinium solution , 40 l sodium acetate (pH 5.0) and reprecipitated
with 400 I isopropanol as bcforc. Thc RNA pellet was washed with 70 
ethanol , dried and resuspend cd in 100 diethy I pyrocarbonate (DEPC)- treated
dH20. Equal counts (approximatcly 3 X 107 CPM) wcre hybridized to plasmid
DNA bound to Zetabind nylon membranes using thc protocol described for RNA
blot analysis.
The following plasmid ON As werc used to detect specific run-on
transcripts: Full length rat NT/N (rbNT), mousc c- fos (pGEMfos3), and c-jun
(JAC1.1) cDNAs containing 700, 2140 and 2600 nt of coding sequences,
respectively. A 366 nt Eco RI-Sph I fragment of mouse a- tubulin (MAT aI
Vilasante et a!. 1986)) and pGEM4 vector DNA werc used as a positive and
negative controls, respectively. Plasmid DNA at 5 g/slot was denatured and
nicked by boiling in 50 l 0. 1 N NaOH for 5 minutes. After denaturation, 360 III
of ice cold 6 X SSC (1 X SSC = 0. 15 M NaCl , 0. 15 M sodium citratc, pH 7.0) was added
and 400 III of this mixture was loaded on Zetabind nylon mcmbranes using a
slot-blot apparatus (Schleicher and Schuell , Keene, N. ). Filters were air-
dried, baked under vacuum for 2 hours at 80 and prewashcd as described for
RNA blot analysis.
139
RNA Isolation. RNA was prcpared by a modirication or the LiCI/urea procedure
(Rhodes 1975). To isolatc total RNA. cclls wcrc harvestcd, washed with 5 ml ice-
cold 1 X PBS, resuspended in 1 ml or 1 X PBS. and lysed by the addition of an
equal volumc or 8 M urea. 8 M LiCI. The solution was sonicatcd to reduce
viscosity (Branson J- 17 A sonicator, microprobe. 5 setting), incubated
overnight at 4 oC, and the RNA was recovered by centrifugation at 10,000 X g
for 30 minutes. RNA was rcsuspendcd in TES buffcr (10 mM Tris-HCI , 5 
EDTA, 0. 1% SDS. pH 7.4), extractcd with phenol and chloroform , cthanol
precipitated. and dissolvcd in DEPC-lrcalcd H2 O. For the preparation of nuclear
and cytoplasmic RNA , nuclei were isolated as described for the nuclear run-on
transcription assay. The nuclear pellet was washed with 2 ml double detergent
buffer (l % NP-40, 0. 5% deoxycholate, 10 11M NaCI, 10 mM Tris- HCI , 1.5 
MgCI2, pH 7.4), the wash supernatal1 was pooled with the cytoplasmic fraction,
and the final nuclear pellel was resuspended in 2 ml double detergent buffer.
RNA was cxtracted rrom each fraction by addition of an equal volume of 8 
urea, 8 M LiCI and processed as describcd above. Synthctic sense strand Ell-
RNA (see below) was added just prior to addition of the LiCI/urea solution as an
internal control ror RNA recovery (1 ngl107 nuclei for nuclear RNA, 4 ng/107
cells for cytoplasmic and 5 ng/107 cclls ror total RNA). PolyA+ RNA was isolated
on oligo(dT) affinity columns as described (Sam brook et al. 1989).
RNa tection Assa Riboprobe synthesis and RNase protection assays
were performed as described (Mellon el al. 1984; Zinn et al. 1983). 32P- labeled
antisense probe RNA was transcribed using T7 RNA polymerase and a-32P- CTP
following linearization of the pGEM- EII-NT or pGEM-rNT4 with Eco RI. Sense
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RNA standards wcrc transcribed uSIng SP6 RNA polymcrase following
linearization of thc pEII-NT tcmplatc with Rsa I. RNA samples (10-25 Ilg
nuclear RNA, 5- 10 Ilg cytoplasmic or total RNA) were hybridized overnight
with 32P- labcled probc (100,000 cpm) in hybridization buffer (80% formamide,
40 mM PIPES, pH 6.7, 0.4 M NaCI, I mM EDTA) at 45 oc. Samples were digested
with nuclcase PI (20 Ilg/ml) and ribonuclease Tl(1llg/ml) as described
(Ausubel ct aI. 1989: Brewer and Ross 1988), extracted with phenol and
chloroform , cthanol prccipitatcd artcr the addition of carricr yeast RNA (10
Ilg), and analyzcd on 8M urca/6% polyacrylamide sequencing gels. RNase
protection products wcrc quantitatcd either uSllg a petascope 603 Blot
Analyzer (Petagen , Waltham, MA) or by scanning autoradiograms usmg a
Hoeffer GS300 densitomctcr and GS-365 PS DaLa Systcm. Signals resulting from
the internal standard RNA werc uscd to corrcct for small variations in sample
recovery.
32P- labclcd antiscnse RNA (623 nucleoLidcs) corresponding to the (X-
tubulin gene was Lranscribcd with SP6 RNA polymerase arLCr lincarization of
the template with Hind II I. Hybridization to RNAs containing intron 3 results
in a 562 nucleotide proLccted fragment while hybridization to spliced RNAs
results in a 383 nucleotide product. To produce 32 P- Iabcled RN A markers, a
fragment of the rat gene, rNT 1. 8 subcloned into pGEM 4 (Kislauskis et aI. 1988),
was linearized with the following rcstriction enzymes; Ora I, Hinf I, Ava II,
Pvu II, Hae Il , Rsa I, and Hind III. Following transcription with SP6 RNA
polymerase, RNA fragments or thc following molccular weights were obtained;
496, 305, 242, 196, 158, 113, and 65 nt, respcctivcly.
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RNA Blot Anal sis. Total RNA (20 J.g) was size- fractionated on 1 % agarose gels
containing 0.6 M formaldchyde and blotted onto Zetabind nylon membranes
using standard procedures (Sambrook et al. 1989). Filters were incubated in 0.
x SSC, 1 % SDS at 65 o C for I hour , prchybridized in 50% formamide, 3 X SSC, 50
mM sodium phosphatc, pH 7. , 1 % SDS, 5 X Denhardt s, 10 mM EDTA, and 1
mg/ml yeast RNA for 4 hours at 45 oC and hybridizcd ovcrnight at 45 o with
32P-labelcd riboprobes in prchybridization buffer containing 1 X Denhardt
Filters were wash cd with scveral changes of 1 X SSC, 0. 1 % SDS at room
temperature followcd by one or more washes with 0. 1 X SSC, 0. 1 % SDS, and 0. 1 %
sodium pyrophosphatc at 60-65 o c. AP- l cDNAs subcloned into RNA expression
vectors werc used to synthesi/.e 32P- labeled antisensc RNA probes as described
(Ausubel et al. 1989). T7 RNA polymerase was uscd to transcribe c-fos
(pGEMfos3), fra- and c-jUtl (JAC.l) af'ter lincarization of tcmplates with
either Bst Ell (c-fos ), Stu (fra-1) or Nae I (c-jun). SP6 RNA polymerase was
used to transcribc fo.\ B (pGEM- AClI3), fra- and jun- (465.20) after
linearization with Sma I , Bam HI, and Nar I, respectivcly. A 32P- labeled DNA
probe for jun- was prcparcd by random primcd synthesis of a Sph I cDNA
fragment of pXHJ- 12.4 (Ryder el al. 1989).
sis rotcin s nthesis inhibition efficienc PC 12 ccll s were treated
with either anisomycin or cycloheximide for various times and protein
synthesis, RNA synthcsis and ccll viability was analyzed. Protein synthesis was
determined by mcasuring thc incorporation of 35 S-meLhionine into acid
insoluble matcrial. 1 X 106 cells wcre labeled with 35 S-mcthionine (50 IlCi) in
serum-supplimented OM EM al 37 oC in a C02 incubator. At the appropriate time
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points, cells wcrc harvcstcd, washcd in 1 X PBS, solubilized in 1 ml SUM buffer
(1 % SDS, 0.5 M urea, 1 ME) and boilcd for 5 minutcs. 20 IJI of this solution
were precipitated with 10% trichloroacetic acid (TCA) on ice for 30 minutes,
passed through glass fibcr filtcrs and washcd with icc-cold 5% TCA. The fiters
were air-dried, added to scintillation fluid, and counLed on a LKB Rackbeta
scintillation counter (Pharmacia LKB Biotechnolgies, Piscataway, N.
). 
RNA
synthesis was detcrmined similarly, cxcept cells wcrc pulsc- labclcd with 20 IlCi
3H-uridine. In both cascs, acid- insolublc counts were comparcd to total
cellular counts to adjust for thc cIlecLs of protein synthesis inhibitors on
methionine and uridine uptake (McKnight 1978). Cell viability was determined
by dye exclusion. Viable cclls were counted on a hemocytometer after
treatment with 0.04% Lrypan bluc in 1 X PBS.
rotein Kinase C dcterminations. PKC activity in PC12 cclls was determined as
describcd (Palfrcy and Wasccm 1985). Approximately 1 X 107 induced PC12 cells
were harvested, washed in 10 ml icc cold 1 X PBS and rcsuspended in 1 ml ice
cold extraction buffcr (50 mM Tris- HCI, 50 mM , 1 mM phenyl methyl-
sulfonyl fluoride (PMSF), 2 mM EGT A , pH 7. 5). This suspension was sonicated
for 2 minutes and centrifuged (800 X g) for 10 minutcs at 4 oC. The supernatant
was decantcd to a ncw tubc and centrifuged (120,000 X g) for 30 minutes at 4 o
to pellet the membranc fraction. The supernatant was saved (cytosolic
fraction) while the membranc pcllcL was resuspended in 1 ml ice cold
extraction buffcr with 10 IJI Triton X- I 00. and incubatcd on ice 30 minutes. Both
fractions werc stored at -70 o
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In vitro phosphorylalion of' histonc H 1 was used to assay for PKC
activity in the cytosolic and mcmbrane fractions of PC12 ceIls. Equal amounts
of protein (5 J.g) from each fraction (dctermined by Bradford assay) were
mixed with 800 /11 of 100 mM Tris- HCI , 5 mM MgS04, 0, mg/ml histonc HI , 50 /1M
32p-ATP (500 mCi/mmol), pH 7.4. These rcactions wcre incubated for 5
minutes at 30 oC and thcn placcd on ice to stop the reaction. For PKC specific
phosphorylation, 500 /1M CaCI and 50 /1g/ml phoshotidylserine were included,
whereas 500 J.M EGTA was included as a non-specific phosphorylation control.
20/11 of the above samples werc added to an equal volume of 2 SDS/gel loading
buffer, boiled for 5 minutcs and loaded on 15% SDS/PAGE (Laemmli 1970).
Phosphorylated histones were dctccted by autoradiography and quantitated by
scanning the autoradiograms using a Hoefler GS300 densitometer and GS-365
PS Data Systcm.
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